Metadiamide compound and application thereof as pesticide
By designing m-diamide compounds with strong lipophilicity and reduced hydrogen bonding of water molecules, the problems of pest resistance and environmental pollution have been solved, achieving rapid and low-toxicity insecticidal effects.
Patent Information
- Application Number
- CN202410976057.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-19
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-07-19
AI Technical Summary
Existing pesticides have led to pesticide resistance in pests due to long-term use and pose environmental pollution risks, necessitating the development of new pesticides to address this issue.
A meta-diamide compound is provided, which, through specific structural design, enhances lipophilicity, weakens hydrogen bond formation in water molecules, increases enzyme metabolism rate in vivo, rapidly produces drug efficacy, and avoids drug resistance.
This compound has rapid efficacy, low dosage and low toxicity against pests, and is particularly effective against resistant rice stem borers, diamondback moths and aphids, and is not prone to developing resistance.
Smart Images

Figure CN118908850A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of organic compounds, and in particular to a meta-diamide compound and an application thereof as a pesticide. Background Art
[0002] In the production process of agriculture, forestry, ornamental plants, and nursery crops, insect pests have caused great losses to economic property, and pesticides are widely used in agricultural production and agricultural planting. With the large-scale and long-term use of pesticides, pests have developed resistance to the existing large number of pesticides, and the dosage must be increased to achieve the original effect, causing certain problems for agricultural production, the environment, and ecology. For example, in the rice planting process, chlorantraniliprole is an efficient insecticide for controlling rice stem borers, but after years of continuous use, serious resistance problems have now appeared in most parts of the world, greatly threatening global rice production. Therefore, it is necessary to continue to develop new pesticides with high activity, fast efficacy, low toxicity and environmental friendliness. Summary of the invention
[0003] In view of this, the present application provides an isocyanamide compound and its application as a pesticide. The isocyanamide compound has no cross-resistance with existing insecticides. The compound has the advantages of fast efficacy, low dosage, low toxicity and environmental friendliness on plant pests, especially excellent preventive effect on rice-resistant Chilo suppressalis, diamondback moth, aphids, etc.
[0004] In the first aspect of the present application, there is provided a diamide compound as shown in formula (I):
[0005]
[0006] In formula (I), Q is any one of a substituted or unsubstituted phenyl group and a substituted or unsubstituted heterocyclic group;
[0007] R1 is any one of substituted or unsubstituted C3-C9 cycloalkyl, substituted or unsubstituted C2-C8 epoxyalkyl, substituted or unsubstituted phenyl, substituted or unsubstituted heterocyclic group, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted C1-C6 alkylthio, substituted or unsubstituted C2-C6 alkenyl, substituted or unsubstituted C2-C6 alkynyl, substituted C1-C6 alkyl, hydrogen atom, cyano, amino, hydroxyl, thiol; wherein the substituent group when R1 is substituted C1-C6 alkyl is selected from cyano, nitro, hydroxyl, carboxyl, thiol, sulfonyl substituted or unsubstituted phenyl, substituted or unsubstituted heterocyclic group, substituted or unsubstituted amino, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, C1-C6 substituted or unsubstituted alkyl, C3-C6 substituted or unsubstituted cycloalkyl, C1-C6 substituted or unsubstituted alkoxy, C2-C6 substituted or unsubstituted alkenyl, C2-C6 substituted or unsubstituted alkynyl, substituted or unsubstituted -Si(C1-C6 alkyl)3 or one or more;
[0008] or a group represented by -L1-M-L2, wherein L1 is selected from substituted or unsubstituted phenylene, substituted or unsubstituted heterocyclic group, substituted or unsubstituted imino, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted C1-C6 alkylene, substituted or unsubstituted C3-C9 cycloalkylene, substituted or unsubstituted C1-C6 alkyleneoxy, substituted or unsubstituted C1-C6 alkylenethio, substituted or unsubstituted C2-C8 epoxyalkylene, substituted or unsubstituted C2-C6 alkenylene, substituted or unsubstituted C2-C6 alkynylene, substituted or unsubstituted any one of a substituted C2-C6 alkenyleneoxy group and a substituted or unsubstituted C2-C6 alkynyleneoxy group; M is selected from any one of an oxygen atom, a sulfur atom, a carbonyl group, a sulfone group, a sulfoxide group, and an imino group; L2 is selected from any one of a hydrogen atom, a substituted or unsubstituted phenyl group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted alkoxycarbonyl group, a substituted or unsubstituted alkenyloxycarbonyl group, a substituted or unsubstituted alkynyloxycarbonyl group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C3-C9 cycloalkyl group, a substituted or unsubstituted C1-C6 alkoxy group, a substituted or unsubstituted C2-C6 alkenyl group, and a substituted or unsubstituted C2-C6 alkynyl group;
[0009] R2 is selected from any one of a hydrogen atom, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C2-C6 alkenyl group, a substituted or unsubstituted C2-C6 alkynyl group, a substituted or unsubstituted C3-C6 cycloalkyl group, a substituted or unsubstituted C1-C6 alkylcarbonyl group, a substituted or unsubstituted C2-C6 alkenylcarbonyl group, a substituted or unsubstituted C2-C6 alkynylcarbonyl group, and a substituted or unsubstituted C3-C6 cycloalkylcarbonyl group;
[0010] X1 and X2 are independently selected from any one of a hydrogen atom, a fluorine atom, a cyano group or a nitro group, and X1 and X2 are not hydrogen atoms at the same time;
[0011] Y1 and Y3 are each independently any one of a hydrogen atom, a halogen atom, a cyano group, a nitro group, a C1-C6 substituted or unsubstituted alkyl group, and a C1-C6 substituted or unsubstituted alkoxy group;
[0012] Y2 is a C2-C6 haloalkyl group;
[0013] W is an oxygen atom or a sulfur atom.
[0014] In the embodiment of the present application, when R1 is a substituted C2-C8 epoxyalkyl group, a substituted C3-C9 cycloalkyl group, a substituted phenyl group, a substituted heterocyclic group, a substituted alkenyloxycarbonyl group, a substituted alkynyloxycarbonyl group, a substituted C1-C6 alkylthio group, a substituted C2-C6 alkenyl group, or a substituted C2-C6 alkynyl group, the substituent group is selected from hydrogen atoms, halogen atoms, cyano groups, nitro groups, hydroxyl groups, carboxyl groups, mercapto groups, sulfonyl groups, sulfinyl groups, carbamoyl groups, aminosulfonyl groups, aminosulfinyl groups, substituted or unsubstituted phenyl groups. substituted or unsubstituted heterocyclic group, substituted or unsubstituted amino group, substituted or unsubstituted alkoxycarbonyl group, substituted or unsubstituted alkenyloxycarbonyl group, substituted or unsubstituted alkynyloxycarbonyl group, C1-C6 substituted or unsubstituted alkyl group, C3-C6 substituted or unsubstituted cycloalkyl group, C1-C6 substituted or unsubstituted alkoxy group, C2-C6 substituted or unsubstituted alkenyl group, C2-C6 substituted or unsubstituted alkynyl group, substituted or unsubstituted -Si(C1-C6 alkyl)3 or one or more;
[0015] The substituents when L1 or L2 is a substituted group are independently selected from one or more of a hydrogen atom, a halogen atom, a cyano group, a nitro group, a hydroxyl group, a carboxyl group, a sulfhydryl group, a sulfonyl group, a sulfinyl group, a carbamoyl group, an aminosulfonyl group, an aminosulfinyl group, a substituted or unsubstituted phenyl group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted amino group, a substituted or unsubstituted alkoxycarbonyl group, a substituted or unsubstituted alkenyloxycarbonyl group, a substituted or unsubstituted alkynyloxycarbonyl group, a C1-C6 substituted or unsubstituted alkyl group, a C3-C6 substituted or unsubstituted cycloalkyl group, a C1-C6 substituted or unsubstituted alkoxy group, a C1-C6 substituted or unsubstituted alkylthio group, a C2-C6 substituted or unsubstituted alkenyl group, a C2-C6 substituted or unsubstituted alkynyl group, and a substituted or unsubstituted -Si(C1-C6 alkyl)3;
[0016] When R2 is a substituted C1-C6 alkyl, a substituted C2-C6 alkenyl, a substituted C2-C6 alkynyl, a substituted C3-C6 cycloalkyl, a substituted C1-C6 alkylcarbonyl, a substituted C2-C6 alkenylcarbonyl, a substituted C2-C6 alkynylcarbonyl, or a substituted C3-C6 cycloalkylcarbonyl, the substituent group is selected from one or more of a halogen atom, a cyano group, a C1-C6 substituted or unsubstituted alkoxy group, or a C3-C6 substituted or unsubstituted cycloalkyl group.
[0017] In some embodiments of the present application, Q is any one of substituted or unsubstituted phenyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted thienyl, and substituted or unsubstituted pyrazinyl.
[0018] In the embodiment of the present application, when Q is any one of substituted or unsubstituted phenyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted thienyl, and substituted or unsubstituted pyrazinyl, the substituent in the substituted phenyl, substituted pyridyl, substituted pyrimidinyl, substituted thienyl, and substituted pyrazinyl is selected from one or more of halogen atoms, cyano, nitro, trifluoromethyl, methoxy, and trifluoromethoxy.
[0019] In the embodiment of the present application, R1 is substituted or unsubstituted C2-C8 epoxyalkyl, substituted or unsubstituted C3-C9 cycloalkyl, substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl, substituted or unsubstituted C3-C5 cycloalkyl C1-C3 alkyl, cyano-substituted C1-C6 alkyl, substituted or unsubstituted furanyl, substituted or unsubstituted C1-C6 alkylthio, substituted or unsubstituted C2-C6 alkenyl, substituted or unsubstituted Any one of C2-C6 alkynyl, hydrogen atom, cyano, amino, hydroxyl and thiol; wherein the substituents in the substituted C2-C8 epoxyalkyl, substituted C3-C9 cycloalkyl, substituted C3-C5 cycloalkyl C1-C3 alkyl, substituted furyl, substituted C1-C6 alkylthio, substituted C2-C6 alkenyl and substituted C2-C6 alkynyl are one or more of C1-C3 alkyl, hydrogen atom, halogen atom, cyano or furyl;
[0020] Or a group represented by -L1-M-L2, wherein L1 is selected from any one of substituted or unsubstituted C1-C3 alkylene, substituted or unsubstituted C2-C6 alkenylene, substituted or unsubstituted C1-C3 alkyleneoxy, substituted or unsubstituted C1-C3 alkyleneamino, and substituted or unsubstituted C1-C3 alkoxycarbonyl, wherein the substituted C1-C3 alkylene, substituted C2-C6 alkenylene, substituted C1-C3 alkyleneoxy, substituted C1-C3 alkyleneamino, substituted C1-C3 alkoxycarbonyl The substituents in are one or more of hydrogen atoms, halogen atoms, cyano groups or C1-C3 alkoxy groups; M is selected from oxygen atoms, sulfur atoms or imino groups; L2 is selected from hydrogen atoms, substituted or unsubstituted C1-C3 alkyl groups, substituted or unsubstituted C2-C5 alkenyl groups, substituted or unsubstituted C1-C3 alkoxy groups, wherein the substituents of the substituted C1-C3 alkyl groups, substituted C2-C5 alkenyl groups and substituted C1-C3 alkoxy groups are one or more of hydrogen atoms, halogen atoms, cyano groups, C1-C3 alkoxy groups and C1-C3 alkylthio groups.
[0021] In the embodiment of the present application, R1 is any one of substituted or unsubstituted C3-C5 cycloalkyl, substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl, substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl C1-C3 alkyl, cyano-substituted C1-C6 alkyl, substituted or unsubstituted furanyl, substituted or unsubstituted C1-C3 alkylthio, substituted or unsubstituted C2-C5 alkenyl, substituted or unsubstituted C2-C6 alkynyl, hydrogen atom, cyano ; Wherein, the substituents in the substituted C3-C5 cycloalkyl, substituted C1-C3 alkyl C3-C5 cycloalkyl, substituted C1-C3 alkyl C3-C5 cycloalkyl C1-C3 alkyl, substituted C1-C3 alkoxy, substituted C1-C3 alkylthio C1-C3 alkylamino, substituted furyl, substituted C1-C3 alkoxycarbonyl, substituted C1-C3 alkyl, substituted C2-C5 alkenyl are one or more of halogen atoms, cyano, nitro or furyl;
[0022] Or a group represented by -L1-M-L2, wherein L1 is selected from any one of substituted or unsubstituted C1-C3 alkylene, substituted or unsubstituted C2-C6 alkenylene, and substituted or unsubstituted C1-C3 alkyleneoxy, wherein the substituents in the substituted C1-C3 alkylene, substituted C2-C6 alkenylene, and substituted C1-C3 alkyleneoxy are one or more of halogen atoms, cyano groups, or C1-C3 alkoxy groups; M is selected from oxygen atoms; L2 is selected from hydrogen atoms, substituted or unsubstituted C1-C3 alkyl groups, and substituted or unsubstituted C2-C5 alkenyl groups, wherein the substituents in the substituted C1-C3 alkylene, substituted C2-C5 alkenyl groups are one or more of hydrogen atoms, halogen atoms, cyano groups, C1-C3 alkylthio groups, or C1-C3 alkoxy groups;
[0023] The R2 is a hydrogen atom, a C1-C3 alkyl group, a C2-C5 alkenyl group, a C2-C5 alkynyl group, a C3-C5 cycloalkyl group or a C1-C3 alkyl C1-C3 alkoxy group, a C1-C3 alkylcarbonyl group, a C2-C5 alkenylcarbonyl group, a C2-C5 alkynylcarbonyl group or a C3-C5 cycloalkylcarbonyl group.
[0024] In the embodiment of the present application, X1 and X2 are independently selected from hydrogen atoms or fluorine atoms, and X1 and X2 are not hydrogen atoms at the same time; Y1 and Y3 are independently halogen atoms, C1-C3 haloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy; Y2 is C2-C6 fluoroalkyl; W is an oxygen atom.
[0025] In the embodiment of the present application, X1 is a fluorine atom, X2 is a hydrogen atom; Y1 and Y3 are independently a bromine atom, an iodine atom, a methyl group, a methoxy group, an ethoxy group, a trifluoromethyl group, a pentafluoroethyl group, a trifluoromethoxy group, or a pentafluoroethoxy group; Y2 is a pentafluoroethyl group, a heptafluoroisopropyl group, or a nonafluoro-2-butyl group; and W is an oxygen atom.
[0026] The second aspect of the present application provides a tautomer, enantiomer, diastereomer or a pesticide-acceptable salt thereof of the meta-diamide compound provided in the first aspect.
[0027] The third aspect of the present application provides the use of the diamide compound provided in the first aspect or the tautomer, enantiomer, diastereomer or pesticide-acceptable salt thereof of the diamide compound provided in the second aspect for preparing pesticide drugs in the fields of agriculture, forestry or health.
[0028] The fourth aspect of the present application also provides an insecticide preparation, which includes an active ingredient and an excipient; the active ingredient includes the tautomer, enantiomer, diastereomer or pesticide-acceptable salt of the diamide compound provided in the first aspect and / or the diamide compound provided in the second aspect.
[0029] In the embodiment of the present application, the mass percentage of the active component in the insecticide preparation is 0.1%-99%.
[0030] The fifth aspect of the present application also provides an insecticide composition, which includes active ingredients and other active compounds; the active ingredients include the diamide compounds provided in the first aspect and / or the tautomers, enantiomers, diastereomers or their pesticide-acceptable salts of the diamide compounds provided in the second aspect; the other active compounds include one or more of insecticides, baits, disinfectants, acaricides, nematicides, fungicides, growth regulators and herbicides.
[0031] In the embodiment of the present application, the mass percentage of the active component in the insecticide composition is 1%-99%. DETAILED DESCRIPTION
[0032] The technical solutions in the embodiments of the present application are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present application.
[0033] The present application provides a diamide compound as shown in formula (I):
[0034]
[0035] In formula (I), Q is any one of a substituted or unsubstituted phenyl group and a substituted or unsubstituted heterocyclic group;
[0036] R1 is any one of substituted or unsubstituted C3-C9 cycloalkyl, substituted or unsubstituted C2-C8 epoxyalkyl, substituted or unsubstituted phenyl, substituted or unsubstituted heterocyclic group, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted C1-C6 alkylthio, substituted or unsubstituted C2-C6 alkenyl, substituted or unsubstituted C2-C6 alkynyl, substituted C1-C6 alkyl, hydrogen atom, cyano, amino, hydroxyl, thiol; wherein the substituent group when R1 is substituted C1-C6 alkyl is selected from cyano, nitro, hydroxyl, carboxyl, thiol, sulfonyl substituted or unsubstituted phenyl, substituted or unsubstituted heterocyclic group, substituted or unsubstituted amino, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, C1-C6 substituted or unsubstituted alkyl, C3-C6 substituted or unsubstituted cycloalkyl, C1-C6 substituted or unsubstituted alkoxy, C2-C6 substituted or unsubstituted alkenyl, C2-C6 substituted or unsubstituted alkynyl, substituted or unsubstituted -Si(C1-C6 alkyl)3 or one or more;
[0037] or a group represented by -L1-M-L2, wherein L1 is selected from substituted or unsubstituted phenylene, substituted or unsubstituted heterocyclic group, substituted or unsubstituted imino, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted C1-C6 alkylene, substituted or unsubstituted C3-C9 cycloalkylene, substituted or unsubstituted C1-C6 alkyleneoxy, substituted or unsubstituted C1-C6 alkylenethio, substituted or unsubstituted C2-C8 epoxyalkylene, substituted or unsubstituted C2-C6 alkenylene, substituted or unsubstituted C2-C6 alkynylene, substituted or unsubstituted any one of a substituted C2-C6 alkenyleneoxy group and a substituted or unsubstituted C2-C6 alkynyleneoxy group; M is selected from any one of an oxygen atom, a sulfur atom, a carbonyl group, a sulfone group, a sulfoxide group, and an imino group; L2 is selected from any one of a hydrogen atom, a substituted or unsubstituted phenyl group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted alkoxycarbonyl group, a substituted or unsubstituted alkenyloxycarbonyl group, a substituted or unsubstituted alkynyloxycarbonyl group, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C3-C9 cycloalkyl group, a substituted or unsubstituted C1-C6 alkoxy group, a substituted or unsubstituted C2-C6 alkenyl group, and a substituted or unsubstituted C2-C6 alkynyl group;
[0038] R2 is selected from any one of a hydrogen atom, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C2-C6 alkenyl group, a substituted or unsubstituted C2-C6 alkynyl group, a substituted or unsubstituted C3-C6 cycloalkyl group, a substituted or unsubstituted C1-C6 alkylcarbonyl group, a substituted or unsubstituted C2-C6 alkenylcarbonyl group, a substituted or unsubstituted C2-C6 alkynylcarbonyl group, and a substituted or unsubstituted C3-C6 cycloalkylcarbonyl group;
[0039] X1 and X2 are independently selected from any one of a hydrogen atom, a fluorine atom, a cyano group or a nitro group, and X1 and X2 are not hydrogen atoms at the same time;
[0040] Y1 and Y3 are each independently any one of a hydrogen atom, a halogen atom, a cyano group, a nitro group, a C1-C6 substituted or unsubstituted alkyl group, and a C1-C6 substituted or unsubstituted alkoxy group;
[0041] Y2 is a C2-C6 haloalkyl group;
[0042] W is an oxygen atom or a sulfur atom.
[0043] In the embodiment of the present application, when Q is a substituted phenyl or a substituted heterocyclic group, the substituent group is selected from one or more of a halogen atom, a cyano group, a nitro group, a trifluoromethyl group, a methoxy group, and a trifluoromethoxy group. In the embodiment of the present application, when the substituent group is selected from a halogen atom, the halogen atom may be, for example, one or more of a fluorine atom, a chlorine atom, and a bromine atom. When the substituent group is 2 or more, the substituent group may be the same or different. In the embodiment of the present application, the above-mentioned substituent group may further have a substituent group where possible.
[0044] In some specific embodiments of the present application, when Q is a substituted heterocyclic group, Q can be, for example, a substituted or unsubstituted pyridyl group, a substituted or unsubstituted pyrimidyl group, a substituted or unsubstituted thienyl group, or a substituted or unsubstituted pyrazinyl group.
[0045] In some specific embodiments of the present application, Q can be, for example, phenyl, fluorophenyl, cyanophenyl, trifluoromethylphenyl, difluorophenyl, trifluorophenyl, pyridyl, chloropyridyl, fluoropyridyl, dichlorofluorophenyl, thienyl, pyrimidinyl or pyrazinyl.
[0046] In the embodiment of the present application, when R1 is a substituted C1-C6 alkyl, the substituent group is selected from cyano, nitro, hydroxyl, carboxyl, thiol, sulfonyl, sulfinyl, carbamoyl, aminosulfonyl, aminosulfinyl, substituted or unsubstituted phenyl, substituted or unsubstituted heterocyclic group, substituted or unsubstituted amino, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, C1-C6 substituted or unsubstituted alkyl, C3-C6 substituted or unsubstituted cycloalkyl, C1-C6 substituted or unsubstituted alkoxy, C2-C6 substituted or unsubstituted alkenyl, C2-C6 substituted or unsubstituted alkynyl, substituted or unsubstituted -Si(C1-C6 alkyl)3. In the embodiment of the present application, C1-C6 alkyl refers to C1-C6 chain alkyl, including C1-C6 straight chain alkyl and C1-C6 branched chain alkyl. In some embodiments of the present application, the number of carbon atoms of the C1-C6 alkyl group can be 1, 2, 3, 4, 5, or 6, for example.
[0047] In the embodiment of the present application, when R1 is a substituted C2-C8 epoxyalkyl group, a substituted C3-C9 cycloalkyl group, a substituted phenyl group, a substituted heterocyclic group, a substituted alkenyloxycarbonyl group, a substituted alkynyloxycarbonyl group, a substituted C1-C6 alkylthio group, a substituted C2-C6 alkenyl group, or a substituted C2-C6 alkynyl group, the substituent group is selected from hydrogen atom, halogen atom, cyano group, nitro group, hydroxyl group, carboxyl group, mercapto group, sulfonyl group, sulfinyl group, carbamoyl group, aminosulfonyl group, aminosulfinyl group, substituted or unsubstituted phenyl group. , substituted or unsubstituted heterocyclic group, substituted or unsubstituted amino group, substituted or unsubstituted alkoxycarbonyl group, substituted or unsubstituted alkenyloxycarbonyl group, substituted or unsubstituted alkynyloxycarbonyl group, C1-C6 substituted or unsubstituted alkyl group, C3-C6 substituted or unsubstituted cycloalkyl group, C1-C6 substituted or unsubstituted alkoxy group, C2-C6 substituted or unsubstituted alkenyl group, C2-C6 substituted or unsubstituted alkynyl group, substituted or unsubstituted -Si(C1-C6 alkyl)3 or one or more;
[0048] When L1 or L2 is a substituted group, the substituent group is independently selected from one or more of a hydrogen atom, a halogen atom, a cyano group, a nitro group, a hydroxyl group, a carboxyl group, a sulfhydryl group, a sulfonyl group, a sulfinyl group, a carbamoyl group, an aminosulfonyl group, an aminosulfinyl group, a substituted or unsubstituted phenyl group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted amino group, a substituted or unsubstituted alkoxycarbonyl group, a substituted or unsubstituted alkenyloxycarbonyl group, a substituted or unsubstituted alkynyloxycarbonyl group, a C1-C6 substituted or unsubstituted alkyl group, a C3-C6 substituted or unsubstituted cycloalkyl group, a C1-C6 substituted or unsubstituted alkoxy group, a C1-C6 substituted or unsubstituted alkylthio group, a C2-C6 substituted or unsubstituted alkenyl group, a C2-C6 substituted or unsubstituted alkynyl group, and a substituted or unsubstituted -Si(C1-C6 alkyl)3.
[0049] In the embodiment of the present application, when R2 is a substituted C1-C6 alkyl, a substituted C2-C6 alkenyl, a substituted C2-C6 alkynyl, a substituted C3-C6 cycloalkyl, a substituted C1-C6 alkylcarbonyl, a substituted C2-C6 alkenylcarbonyl, a substituted C2-C6 alkynylcarbonyl, or a substituted C3-C6 cycloalkylcarbonyl, the substituent group is selected from one or more of a halogen atom, a cyano group, a C1-C6 substituted or unsubstituted alkoxy group, or a C3-C6 substituted or unsubstituted cycloalkyl group.
[0050] In the embodiments of the present application, when there are 2 or more substituent groups, the substituent groups may be the same or different. In the embodiments of the present application, the above-mentioned substituent groups may further have substituent groups if possible.
[0051] In the embodiment of the present application, the number of carbon atoms of the C2-C8 epoxyalkyl group can be, for example, 2, 3, 4, 5, 6, 7, 8; the number of carbon atoms of the C3-C9 cycloalkyl group can be, for example, 3, 4, 5, 6, 7, 8, 9; the number of carbon atoms of the C1-C6 alkylthio group can be, for example, 1, 2, 3, 4, 5, 6; the number of carbon atoms of the C2-C6 alkenyl group can be, for example, 2, 3, 4, 5, 6; the number of carbon atoms of the C2-C6 alkynyl group can be, for example, 2, 3, 4, 5, 6. In the embodiment of the present application, the number of carbon atoms of the C1-C6 substituted or unsubstituted alkyl group may be, for example, 1, 2, 3, 4, 5, or 6; the number of carbon atoms of the C3-C6 substituted or unsubstituted cycloalkyl group may be, for example, 3, 4, 5, or 6; the number of carbon atoms of the C1-C6 substituted or unsubstituted alkoxy group may be, for example, 1, 2, 3, 4, 5, or 6; the number of carbon atoms of the C2-C6 substituted or unsubstituted alkenyl group may be, for example, 2, 3, 4, 5, or 6; the number of carbon atoms of the C2-C6 substituted or unsubstituted alkynyl group may be, for example, 2, 3, 4, 5, or 6; the number of carbon atoms of the C1-C6 substituted or unsubstituted alkylthio group may be, for example, 1, 2, 3, 4, 5, or 6.
[0052] In some embodiments of the present application, R1 is substituted or unsubstituted C2-C8 epoxyalkyl, substituted or unsubstituted C3-C9 cycloalkyl, substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl, substituted or unsubstituted C3-C5 cycloalkyl C1-C3 alkyl, cyano-substituted C1-C6 alkyl, substituted or unsubstituted furanyl, substituted or unsubstituted C1-C6 alkylthio, substituted or unsubstituted C2-C6 alkenyl, substituted or unsubstituted Any one of C2-C6 alkynyl, hydrogen atom, cyano, amino, hydroxyl and thiol; wherein the substituents in the substituted C2-C8 epoxyalkyl, substituted C3-C9 cycloalkyl, substituted C3-C5 cycloalkyl C1-C3 alkyl, substituted furyl, substituted C1-C6 alkylthio, substituted C2-C6 alkenyl and substituted C2-C6 alkynyl are one or more of C1-C3 alkyl, hydrogen atom, halogen atom, cyano or furyl;
[0053] Or a group represented by -L1-M-L2, wherein L1 is selected from any one of substituted or unsubstituted C1-C3 alkylene, substituted or unsubstituted C2-C6 alkenylene, substituted or unsubstituted C1-C3 alkyleneoxy, substituted or unsubstituted C1-C3 alkyleneamino, and substituted or unsubstituted C1-C3 alkoxycarbonyl, wherein the substituted C1-C3 alkylene, substituted C2-C6 alkenylene, substituted C1-C3 alkyleneoxy, substituted C1-C3 alkyleneamino, substituted C1-C3 alkoxycarbonyl The substituents in are one or more of hydrogen atoms, halogen atoms, cyano groups or C1-C3 alkoxy groups; M is selected from oxygen atoms, sulfur atoms or imino groups; L2 is selected from hydrogen atoms, substituted or unsubstituted C1-C3 alkyl groups, substituted or unsubstituted C2-C5 alkenyl groups, substituted or unsubstituted C1-C3 alkoxy groups, wherein the substituents of the substituted C1-C3 alkyl groups, substituted C2-C5 alkenyl groups and substituted C1-C3 alkoxy groups are one or more of hydrogen atoms, halogen atoms, cyano groups, C1-C3 alkoxy groups and C1-C3 alkylthio groups.
[0054] In some specific embodiments of the present application, R1 is any one of substituted or unsubstituted C3-C5 cycloalkyl, substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl, substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl C1-C3 alkyl, cyano-substituted C1-C6 alkyl, substituted or unsubstituted furanyl, substituted or unsubstituted C1-C3 alkylthio, substituted or unsubstituted C2-C5 alkenyl, substituted or unsubstituted C2-C6 alkynyl, hydrogen atom, cyano Species; wherein the substituents in the substituted C3-C5 cycloalkyl, substituted C1-C3 alkyl C3-C5 cycloalkyl, substituted C1-C3 alkyl C3-C5 cycloalkyl C1-C3 alkyl, substituted C1-C3 alkoxy, substituted C1-C3 alkylthio C1-C3 alkylamino, substituted furanyl, substituted C1-C3 alkoxycarbonyl, substituted C1-C3 alkyl, substituted C2-C5 alkenyl are one or more of halogen atoms, cyano, nitro or furanyl;
[0055] Or it is a group represented by -L1-M-L2, wherein L1 is selected from any one of substituted or unsubstituted C1-C3 alkylene, substituted or unsubstituted C2-C6 alkenylene, and substituted or unsubstituted C1-C3 alkyleneoxy, wherein the substituents in the substituted C1-C3 alkylene, substituted C2-C6 alkenylene, and substituted C1-C3 alkyleneoxy are one or more of halogen atoms, cyano groups, or C1-C3 alkoxy groups; M is selected from oxygen atoms; L2 is selected from hydrogen atoms, substituted or unsubstituted C1-C3 alkyl groups, and substituted or unsubstituted C2-C5 alkenyl groups, wherein the substituents in the substituted C1-C3 alkylene, substituted C2-C5 alkenyl groups are one or more of hydrogen atoms, halogen atoms, cyano groups, C1-C3 alkylthio groups, or C1-C3 alkoxy groups.
[0056] In some specific embodiments of the present application, R1 can be, for example, cyclopropyl, cyclobutyl, cyclopentyl, ethylcyclopropyl, -ethyl(2-methylcyclopropyl), -methyl(3-methylcyclobutyl), -methyl(3-methylcyclopentyl), -CH2SCH3, -CH2SCH2CH3, -CH2SCH3, -furan-2-yl, -methyl(furan-2-yl), -CH2CN, -C2H4CN, -CH=CH2, -CH2CH=CH2CH3, -C(CH3)=CH2, -C≡CH, -C≡CCH3, -CH2C≡CCH3, -CH2OCH3, -CH2OCH2CH3, -CH2CH2OCH3, -CH2OCH2OCH2Cl or -CH2OCH2CH2OCH3.
[0057] In some embodiments of the present application, the R1 can be, for example, a substituted or unsubstituted C3-C5 cycloalkyl, a substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl, a substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl C1-C3 alkyl, a substituted or unsubstituted C1-C3 alkoxy, a substituted or unsubstituted C1-C3 alkylthio, a substituted or unsubstituted C1-C3 alkylamino, or a substituted or unsubstituted C1-C3 alkoxycarbonyl. When R1 contains a cyclic structure such as a cycloalkyl or heteroatoms such as O, N, or S, the inter-diamide compound has a relatively excellent pest control effect. In some specific embodiments of the present application, the R1 can be, for example, a cyclopropyl, a methylcyclopropyl, an isopropoxy, -CH2OCH3, or -CH2OCH2CH3.
[0058] In the embodiment of the present application, the number of carbon atoms of the C1-C6 alkylcarbonyl group may be, for example, 1, 2, 3, 4, 5, or 6; the number of carbon atoms of the C2-C6 alkenylcarbonyl group may be, for example, 2, 3, 4, 5, or 6; the number of carbon atoms of the C2-C6 alkynylcarbonyl group may be, for example, 2, 3, 4, 5, or 6; the number of carbon atoms of the C3-C6 cycloalkylcarbonyl group may be, for example, 3, 4, 5, or 6.
[0059] In some embodiments of the present application, R2 can be a hydrogen atom, a C1-C3 alkyl group, a C2-C5 alkenyl group, a C2-C5 alkynyl group, a C3-C5 cycloalkyl group, a C1-C3 alkyl C1-C3 alkoxy group, a C1-C3 alkylcarbonyl group, a C2-C5 alkenylcarbonyl group, a C2-C5 alkynylcarbonyl group, or a C3-C5 cycloalkylcarbonyl group. In some specific embodiments of the present application, R2 can be, for example, a hydrogen atom, a methyl group, -CH=CH2, -CH2CH=CH2, -CH2OCH3, -CH3CN, -CH2C≡CH, a cyclopropyl group, -C(O)cyclopropyl group, or -C(O)CH=CH2.
[0060] In some embodiments of the present application, X1 is a fluorine atom; X2 is a hydrogen atom; Y1 and Y3 are independently a bromine atom, an iodine atom, a methyl group, a methoxy group, an ethoxy group, a trifluoromethyl group, a pentafluoroethyl group, a trifluoromethoxy group, or a pentafluoroethoxy group; Y2 is a pentafluoroethyl group, a heptafluoroisopropyl group, or a nonafluoro-2-butyl group; and W is an oxygen atom.
[0061] The present application can enhance the lipophilicity of the diamide compound by selecting suitable groups for R1 and R2 respectively, and the mutual coordination of suitable groups between R1 and R2, and when it is applied to the field of insecticide, it is more easily absorbed by pests, thereby having better insecticidal activity. The diamide compounds commonly used for insecticides on the market currently produce drug effects in organisms through demethylation reactions, but pests will develop drug resistance after long-term use. The diamide compounds provided by the present application produce drug effects in organisms through deacylation reactions, and the diamide compounds of this structure have not yet been applied to the field of insecticides, and the diamide compounds of this structure are not easy to produce drug resistance when used. In addition, the present application specially designs the structure of the intermethyleneimine compound and the grafting positions of R1 and R2, so that the R1 group is connected to the C in C=W, and the C in C=W is grafted on the N connected to the carbonyl group of the intermethyleneimine compound, the polarity is weakened, it is not easy to form hydrogen bonds with water molecules, the hydrophilicity is weakened, and the lipophilicity is enhanced, so that the intermethyleneimine compound has better lipophilicity and can further enhance its insecticidal efficacy. This is because the modified structure has a faster enzyme metabolism rate in the body and is more likely to produce efficacy faster through deacylation reaction in the body.
[0062] The diamide compounds provided in the present application have no cross-resistance with existing insecticides. Compared with existing insecticides on the market, the compounds have the advantages of rapid efficacy, low dosage, low toxicity and environmental friendliness against plant pests, especially against rice-resistant Chilo suppressalis, diamondback moth, aphids, etc.
[0063] The embodiments of the present application provide a tautomer, enantiomer, diastereomer or a pesticide-acceptable salt thereof of the above-mentioned meta-diamide compound.
[0064] The present application also provides an application of the above-mentioned diamide compound or the tautomer, enantiomer, diastereomer or pesticide-acceptable salt thereof for preparing pesticide drugs in the fields of agriculture, forestry or health.
[0065] In the embodiment of the present application, the pests that the pesticide is used to control include but are not limited to beetles (Coleoptera), such as green bean weevils, corn weevils, red flour beetles, potato beetles, fine-breasted beetles, multi-colored scarab beetles, potato leaf beetles, leaf beetles, pine beetles, rice root weevils, brown powder borers; Lepidoptera pests, such as gypsy moths, yellow-brown tent caterpillars, Pieris rapae Japanese subspecies, Spodoptera litura, cabbage armyworm, striped stem borer, corn borer, dried fruit borer, apple moth, yellow cutworm, greater wax moth, cabbage moth, tobacco budworm, citrus leafminer; Hemiptera pests, for example, black-tailed leafhopper, brown planthopper, mealybug, arrow-pointed shield scale, peach aphid, apple aphid, cotton aphid, radish aphid, pear crown lace bug, green toon, greenhouse whitefly; Thysanoptera pests, for example, palm thrips, western flower thrips; Orthoptera pests, for example, African mole cricket, African migratory locust; Blattodea pests, for example, German cockroach, American cockroach, yellow-breasted termite, house termite; Diptera pests, for example, one or more of housefly, Aedes aegypti, gray ground fly, Culex pipiens pallens, Anopheles sinensis, Culex tritaeniorhynchus, and clover leafminer. In some embodiments of the present application, the insecticide drug may also refer to acaricide drugs, and the pests used for prevention and control include but are not limited to spiders (Arachnids), such as mites (Acarina), for example, soft ticks, hard ticks and sarcoptes, such as the long star tick, tropical flower tick, Persian sharp-edged tick, cattle tick, microscopic cattle tick, ricinus tick, gallinae mite, sheep scabies, human scabies; Acarus spp., such as apple rust mite; Tenuiphagus spp., such as Polyphagous tarsonemus; Tenuipalpids spp., such as purple-red short-palped mite; Tetranychus spp., such as cinnabarinus spider mite, Kanzawa spider mite, Pacific spider mite, cotton spider mite and two-spotted spider mite; one or more of apple spider mite and citrus spider mite.
[0066] The embodiment of the present application also provides an insecticide preparation, which includes an active component, and the active component includes the diamide compound provided above and / or the tautomer, enantiomer, diastereomer or its pesticide acceptable salt of the diamide compound provided above; the insecticide preparation also includes one or more excipients.
[0067] In the embodiments of the present application, the pesticide preparation includes, but is not limited to, solutions, emulsions, wettable powders, granular wettable powders, suspensions, powders, foams, pastes, tablets, granules, aerosols, natural agents impregnated with active compounds, synthetic agents impregnated with active compounds, microcapsules, seed coatings, preparations equipped with combustion devices (the combustion devices may be chimneys and fog cylinders, cans and coils, etc.), cold fog agents, hot fog agents, etc. These pesticide preparations or animal parasite control agents may be prepared by known methods, for example, by mixing the active ingredient with a filler (such as a liquid diluent or carrier, a liquefied gas diluent or carrier, a solid diluent or carrier), and optionally with a surfactant (i.e., an emulsifier and / or a dispersant and / or a foaming agent).
[0068] In the embodiments of the present application, the mass percentage of the active component in the insecticide preparation is 0.1%-99%. In some embodiments of the present application, the mass percentage of the active component in the insecticide preparation can be, for example, 1%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 99%. In some specific embodiments of the present application, the mass percentage of the active component in the insecticide preparation can be 0.5%-90%.
[0069] An embodiment of the present application also provides an insecticide composition, which includes active components and other active compounds; the active components include the diamide compounds provided in the previous text of the present application and / or the tautomers, enantiomers, diastereomers or their pesticide-acceptable salts of the diamide compounds provided in the previous text of the present application; the other active compounds include one or more of insecticides, baits, disinfectants, acaricides, nematicides, fungicides, growth regulators and herbicides.
[0070] In the embodiments of the present application, the mass percentage of the active component in the insecticide composition is 1%-99%. In some specific embodiments of the present application, the mass percentage of the active component in the insecticide composition can be, for example, 1%, 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 99%. In some embodiments of the present application, the mass percentage of the active component in the insecticide composition is 20%-70%.
[0071] The insecticide drugs, insecticide preparations and insecticide compositions provided in the present application have no cross-resistance with existing insecticides. Compared with existing insecticides on the market, the compounds have the advantages of rapid efficacy, low dosage, low toxicity and environmental friendliness against plant pests, especially excellent preventive effects against rice-resistant Chilo suppressalis, diamondback moth, aphids, etc.
[0072] The embodiments of the present invention are further described below with reference to a plurality of embodiments.
[0073] Specifically, the isocyanamide compounds described in the present application are shown in formula (II), and some of the isocyanamide compounds are shown in Table 1, but the isocyanamide compounds described in the present invention are not limited to all the compounds in Table 1.
[0074]
[0075] Table 1: Meta-diamide compounds having the chemical structure shown in formula (II):
[0076]
[0077]
[0078]
[0079]
[0080]
[0081]
[0082]
[0083]
[0084]
[0085]
[0086]
[0087]
[0088]
[0089]
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098]
[0099]
[0100]
[0101]
[0102]
[0103] Example 1
[0104] Preparation method of compound No. 146 in Table 1: (1) Synthesis of tert-butyl 2-fluoro-3-nitrobenzoate
[0105]
[0106] At room temperature, di-tert-butyl dicarbonate (18.62 mL, 81.03 mmol), triethylamine (14.98 mL, 108.04 mmol) and 4-dimethylaminopyridine (1.98 g, 16.21 mmol) were added to a solution of 2-fluoro-3-nitrobenzoic acid (10 g, 54.02 mmol) in dichloromethane (100 mL) respectively. Then, the reaction solution was stirred at room temperature for 18 h. After the reaction was completed by TLC detection, the reaction solution was poured into water (100 mL) for quenching, allowed to stand, separated, the aqueous phase was extracted with dichloromethane (50 mL), and the organic phases were combined. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product. The crude product was purified by flash column chromatography (petroleum ether: ethyl acetate = 99:1) to obtain a light yellow oil (8.34 g, yield 64.00%).
[0107] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 8.35-8.31 (m, 1H), 8.18-8.13 (m, 1H), 7.54-7.50 (m, 1H), 1.55 (s, 9H).
[0108] (2) Synthesis of tert-butyl 2-fluoro-3-aminobenzoate
[0109]
[0110] At room temperature and under nitrogen protection, 10% palladium on carbon (2.4 g) was added to a solution of tert-butyl ester (8.34 g, 34.57 mmol) in ethyl acetate (200 mL). The reaction mixture was then replaced with hydrogen three times, and the reaction mixture was stirred for 18 h under a hydrogen (15 Psi) environment. The reaction was detected by TLC to be complete, and the reaction mixture was filtered through a diatomaceous earth layer, the filter cake was washed with ethyl acetate (50 mL), and the filtrate was concentrated to obtain a crude product. The crude product was purified by rapid column chromatography (petroleum ether: ethyl acetate = 90:10) to obtain a light yellow oil (6.10 g, yield 83.52%).
[0111] The H NMR spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 6.94-6.85 (m, 3H), 5.32 (s, 2H), 1.52 (s, 9H).
[0112] (3) Synthesis of tert-butyl 3-benzamido-2-fluorobenzoate
[0113]
[0114] At room temperature, tert-butyl 3-amino-2-fluorobenzoate (2.10 g, 9.94 mmol) and triethylamine (4.13 mL, 29.82 mmol) were added to a dichloromethane (25 mL) solution, and then a solution of benzoyl chloride (1.27 mL, 10.94 mmol) was slowly added dropwise. After the addition was complete, the reaction solution was stirred at room temperature for 2 h. LCMS monitored the reaction to be complete, the reaction solution was poured into water (30 mL), extracted three times with ethyl acetate (60 mL), the organic phases were combined, the organic phases were washed once with saturated brine (20 mL), then dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product. The crude product was slurried with petroleum ether (50 mL), filtered, the filter cake was washed with petroleum ether (30 mL), and vacuum dried to obtain a white solid (2.40 g, yield 76.56%).
[0115] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.23 (s, 1H), 8.01-7.98 (m, 2H), 7.84-7.80 (m, 1H), 7.69-7.60 (m, 2H), 7.56-7.52 (m, 2H), 7.31 (t, J = 7.9 Hz, 1H), 1.55 (s, 9H).
[0116] (4) Synthesis of tert-butyl 3-(N-acryloylbenzamido)-2-fluorobenzoate
[0117]
[0118] Under an ice bath, add tert-butyl 3-benzamido-2-fluorobenzoate (2.00 g, 7.32 mmol) to a tetrahydrofuran (50 mL) solution, then slowly add sodium hydride (0.63 g, 15.85 mmol) in batches until all are added, replace with nitrogen 3 times, and continue to react for 20 minutes. Then slowly add a tetrahydrofuran (5 mL) solution of acryloyl chloride (1.29 mL, 15.85 mmol) to the above reaction system. After the addition is complete, the reaction solution continues to stir under an ice bath for 1 h. LCMS monitoring of the reaction is completed, the reaction solution is poured into an aqueous ammonium chloride solution (20 mL) to quench, extracted 3 times with ethyl acetate (50 mL), and the organic phases are combined. The organic phase is washed once with saturated brine (20 mL), then dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product. The crude product was purified by silica gel column chromatography (ethyl acetate:petroleum ether=0-20%) to give a white solid (0.70 g, yield 29.88%).
[0119] The hydrogen nuclear magnetic resonance spectrum (600 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 7.84-7.80 (m, 1H), 7.73-7.69 (m, 1H), 7.67-7.65 (m, 2H), 7.57-7.53 (m, 1H), 7.47-7.43 (m, 2H), 7.33 (t, J = 7.9 Hz, 1H), 6.56-6.49 (m, 1H), 6.34-6.29 (m, 1H), 5.89-5.86 (m, 1H), 1.52 (s, 9H).
[0120] (5) Synthesis of 3-(N-acryloylbenzamido)-2-fluorobenzoic acid
[0121]
[0122] At room temperature, tert-butyl 3-(N-acryloylbenzamide)-2-fluorobenzoate (1.30 g, 3.52 mmol) was added to a dichloromethane (20 mL) solution, and then a trifluoroacetic acid (7 mL, 91.48 mmol) solution was slowly added dropwise. After the addition was complete, the mixture was stirred at room temperature for 2 h. The reaction was monitored by LCMS, and the reaction solution was concentrated to obtain a crude product. The crude product was purified by preparative HPLC (Puningtech-Pntulips-C18-10 μm-30*250 mm (A: 0.1% FA / H2O B: ACN = 80-20%)) to obtain a light yellow solid (0.60 g, yield 54.06%).
[0123] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 13.49 (s, 1H), 7.88-7.84 (m, 1H), 7.72-7.68 (m, 1H), 7.66-7.64 (m, 2H), 7.57-7.52 (m, 1H), 7.46-7.42 (m, 2H), 7.33 (t, J = 7.9 Hz, 1H), 6.58-6.52 (m, 1H), 6.32 (dd, J = 1.5, 16.9 Hz, 1H), 5.90-5.87 (m, 1H).
[0124] (6) Synthesis of 3-(N-acryloylbenzamide)-2-fluoro-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide
[0125]
[0126] Dissolve 3-(N-acryloylbenzamide)-2-fluorobenzoic acid (0.40g, 1.28mmol) in ultra-dry dichloromethane, add oxalyl chloride (0.32g, 2.56mmol) under ice bath, then add 1-2 drops of N,N-dimethylformamide, react at room temperature for 2-3h, and concentrate under reduced pressure to obtain 3-(N-acryloylbenzamide)-2-fluorobenzoyl chloride. Dissolve 3-(N-acryloylbenzamide)-2-fluorobenzoyl chloride in acetonitrile, heat to 50℃-60℃, then add 4-(perfluoropropane-2-yl)-2-(trifluoromethyl)aniline (0.42g, 1.28mmol). Keep the temperature constant until the reaction is completed. After reduced pressure concentration, purify by silica gel column chromatography to obtain a white solid (0.46g, yield 57.50%).
[0127] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.53 (s, 1H), 8.11 (d, J = 8.6 Hz, 1H), 8.02-7.97 (m, 1H), 7.94 (s, 1H), 7.79-7.67 (m, 4H), 7.58-7.52 (m, 1H), 7.50-7.38 (m, 3H), 6.56 (dd, J = 16.9, 10.3 Hz, 1H), 6.35 (dd, J = 16.9, 1.5 Hz, 1H), 5.90 (dd, J = 10.3, 1.5 Hz, 1H).
[0128] Example 2
[0129] Preparation method of compound No. 147 in Table 1:
[0130]
[0131] 3-(N-acryloylbenzamide)-2-fluoro-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide (0.40g, 0.64mmol) was dissolved in acetonitrile, sodium hydroxide (0.04g, 0.96mmol) was added, and the mixture was stirred for 10min under ice bath, and N-bromosuccinimide (0.23g, 1.28mmol) was added, and the mixture was reacted for 2.5h-3.5h. After the reaction, the sodium hydroxide was filtered off, the mixture was spin-dried, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2mol / L), saturated sodium carbonate solution and saturated sodium sulfite solution in a ratio of 1:1, and saturated sodium chloride solution in sequence, and the mixture was dried over anhydrous sodium sulfate and spin-dried to obtain the product as a white solid (0.26g, yield 57.78%).
[0132] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.84 (s, 1H), 8.44 (s, 1H), 7.96 (s, 1H), 7.76-7.67 (m, 4H), 7.58 (t, J = 7.4 Hz, 1H), 7.46 (dd, J = 12.5, 5.0 Hz, 3H), 6.55 (dd, J = 16.9, 10.3 Hz, 1H), 6.34 (dd, J = 16.9, 1.5 Hz, 1H), 5.90 (dd, J = 10.3, 1.5 Hz, 1H).
[0133] Example 3
[0134] Preparation method of compound No. 155 in Table 1: (1) Synthesis of methyl 3-benzamido-2-fluorobenzoate
[0135]
[0136] Add 3-amino-2-fluorobenzoic acid methyl ester (3.00 g, 17.74 mmol) to the reaction bottle, dissolve it with dichloromethane, add pyridine (3.16 g, 39.92 mmol), and drop benzoyl chloride (2.49 g, 17.74 mmol) in an ice bath. After the reaction, wash with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated sodium chloride solution in sequence, dry with anhydrous sodium sulfate, and spin dry to obtain the product as a pink solid (4.35 g, yield 89.69%).
[0137] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.25 (s, 1H), 8.03-7.96 (m, 2H), 7.92-7.84 (m, 1H), 7.75 (ddd, J = 8.1, 6.6, 1.7 Hz, 1H), 7.63 (ddd, J = 6.5, 3.8, 1.2 Hz, 1H), 7.55 (dd, J = 10.2, 4.6 Hz, 2H), 7.36 (t, J = 7.9 Hz, 1H), 3.88 (s, 3H).
[0138] ESI-MS (m / z): [MH-] Calculated value: 272.0728, found value: 272.0731.
[0139] (2) Synthesis of 3-Benzamido-2-fluorobenzoic acid
[0140]
[0141] Method 1: Add 3-benzamido-2-fluorobenzoic acid methyl ester (3.00 g, 10.98 mmol) to a mixture of 5% potassium hydroxide solution and methanol in a volume ratio of 1:1, and hydrolyze at 25°C-35°C for 3 h-4 h. After the reaction is completed, dilute hydrochloric acid is added to acidify, and solids are precipitated. The solids are filtered and washed with distilled water several times and then dried to obtain the product as a light pink solid (2.42 g, yield 84.91%).
[0142]
[0143] Method 2: Dissolve 3-amino-2-fluorobenzoic acid (3.00 g, 19.34 mmol) in saturated sodium carbonate solution, dissolve benzoyl chloride (2.99 g, 21.27 mmol) in ethyl acetate and add, react overnight, acidify the inorganic phase with dilute hydrochloric acid, solid precipitates, filter and rinse with distilled water several times and dry to obtain the product as a light pink solid (2.50 g, yield 49.90%).
[0144] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 13.32 (s, 1H), 10.21 (s, 1H), 7.99 (dd, J = 5.2, 3.3 Hz, 2H), 7.87-7.77 (m, 1H), 7.75-7.70 (m, 1H), 7.65-7.59 (m, 1H), 7.58-7.50 (m, 2H), 7.32 (t, J = 7.9 Hz, 1H).
[0145] ESI-MS (m / z): [MH-] Calculated value: 258.0572, found value: 258.0569.
[0146] (3) Synthesis of 3-Benzamido-2-fluorobenzoic acid benzyl ester
[0147]
[0148] Add 3-benzamido-2-fluorobenzoic acid (3.00 g, 11.57 mmol) and thionyl chloride (10 ml) to the reaction flask, stir and react for 3 h-4 h under reflux conditions, and concentrate under reduced pressure to obtain 3-benzamido-2-fluorobenzoyl chloride. Add 3-benzamido-2-fluorobenzoyl chloride and pyridine (1.37 g, 17.36 mmol) to a solution of benzyl alcohol (1.88 g, 17.36 mmol) in acetonitrile (20 ml) and react overnight. Wash with saturated sodium carbonate solution, dilute hydrochloric acid (2 mol / L), and saturated sodium chloride solution in sequence, dry over anhydrous sodium sulfate, and spin dry to obtain the product as a lavender solid (3.60 g, yield 89.11%).
[0149] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.26 (s, 1H), 8.00 (d, J = 7.3 Hz, 2H), 7.89 (t, J = 6.9 Hz, 1H), 7.78 (t, J = 6.6 Hz, 1H), 7.67-7.31 (m, 9H), 5.39 (s, 2H).
[0150] ESI-MS (m / z): [M+Na + ]Theoretical value: 372.1012, measured value: 372.1004.
[0151] (4) Synthesis of 3-(N-(cyclopropanecarbonyl)benzamido)-2-fluorobenzoic acid benzyl ester
[0152]
[0153] 3-Benzamido-2-fluorobenzoic acid benzyl ester (3.00 g, 8.59 mmol) was dissolved in dichloromethane, 4-dimethylaminopyridine (0.10 g, 0.86 mmol) and triethylamine (1.74 g, 17.18 mmol) were added, and cyclopropylcarbonyl chloride (1.35 g, 12.89 mmol) was added after stirring for a while, and the reaction was carried out at 35°C-39°C, and the plate was detected until the reaction was completed. After the reaction was completed, it was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, and then spin-dried to obtain a product as a pink oily viscous liquid (3.02 g, yield 84.12%).
[0154] The hydrogen nuclear magnetic resonance spectrum (600 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 7.94 (t, J = 6.7 Hz, 1H), 7.82 (t, J = 6.9 Hz, 1H), 7.68 (d, J = 7.4 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.50-7.35 (m, 8H), 5.37 (s, 2H), 1.95-1.87 (m, 1H), 0.93 (ddd, J = 10.8, 7.2, 3.1 Hz, 4H).
[0155] ESI-MS (m / z): [M+Na + ]Theoretical value: 440.1274, measured value: 440.1264.
[0156] (5) Synthesis of 3-(N-(cyclopropanecarbonyl)benzamido)-2-fluorobenzoic acid
[0157]
[0158] Benzyl 3-(N-(cyclopropanecarbonyl)benzamido)-2-fluorobenzoate (3.00 g, 7.19 mmol) was dissolved in ethyl acetate, 0.60 g of 5% palladium carbon (55% water) was added, hydrogen was introduced, and the reaction was continued for 24 h. After the reaction was completed, the palladium carbon was filtered off and dried to obtain a white solid (1.13 g, yield 48.09%).
[0159] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 13.46 (s, 1H), 7.92-7.85 (m, 1H), 7.77-7.71 (m, 1H), 7.70-7.65 (m, 2H), 7.59-7.52 (m, 1H), 7.46 (t, J = 7.5 Hz, 2H), 7.34 (dd, J = 13.7, 5.8 Hz, 1H), 1.96-1.84 (m, 1H), 1.01-0.87 (m, 4H).
[0160] ESI-MS (m / z): [MH-] Calculated value: 326.0834, found value: 326.0832.
[0161] (6) Synthesis of 3-(N-(cyclopropanecarbonyl)benzamide)-2-fluoro-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide
[0162]
[0163] 3-(N-(cyclopropanecarbonyl)benzamide)-2-fluorobenzoic acid (1.00 g, 3.06 mmol) was dissolved in ultra-dry dichloromethane, oxalyl chloride (0.78 g, 6.12 mmol) was added under ice bath, and 1-2 drops of N,N-dimethylformamide were added dropwise, and the mixture was reacted at room temperature for 2-3 hours, and concentrated under reduced pressure to obtain 3-(N-(cyclopropanecarbonyl)benzamide)-2-fluorobenzoyl chloride. 3-(N-(cyclopropanecarbonyl)benzamide)-2-fluorobenzoyl chloride was dissolved in acetonitrile, and 4-(perfluoropropane-2-yl)-2-(trifluoromethyl)aniline (1.01 g, 3.06 mmol) was added after heating to 50°C-60°C. The temperature was maintained until the reaction was completed. After concentration under reduced pressure, the mixture was purified by silica gel column chromatography to obtain a white solid (1.06 g, yield 54.36%).
[0164] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.52 (s, 1H), 8.12 (d, J = 8.6 Hz, 1H), 7.99 (d, J = 8.6 Hz, 1H), 7.94 (s, 1H), 7.75 (ddd, J = 20.0, 11.8, 4.7 Hz, 4H), 7.58 (t, J = 7.4 Hz, 1H), 7.47 (dt, J = 21.1, 7.8 Hz, 3H), 1.93-1.86 (m, 1H), 1.01-0.89 (m, 4H).
[0165] ESI-MS (m / z): [MH-] Calculated value: 637.0991, found value: 637.1001.
[0166] Example 4
[0167] Preparation method of compound No. 156 in Table 1:
[0168]
[0169] 3-(N-(cyclopropanecarbonyl)benzamide)-2-fluoro-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide (1.00 g, 1.57 mmol) was dissolved in acetonitrile, sodium hydroxide (0.09 g, 2.36 mmol) was added, and the mixture was stirred for 10 min under an ice bath, and N-bromosuccinimide (0.56 g, 3.14 mmol) was added, and the mixture was reacted for 2.5 h to 3.5 h. After the reaction, the sodium hydroxide was filtered off, the mixture was spin-dried, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution and saturated sodium sulfite solution in a ratio of one, and saturated sodium chloride solution in sequence, and the mixture was dried over anhydrous sodium sulfate and spin-dried to obtain the product as a white solid (0.63 g, yield 55.75%).
[0170] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.83 (s, 1H), 8.43 (s, 1H), 7.97 (s, 1H), 7.75 (ddd, J = 17.5, 8.7, 1.4 Hz, 4H), 7.61-7.56 (m, 1H), 7.48 (dt, J = 12.5, 7.8 Hz, 3H), 1.92-1.84 (m, 1H), 0.95 (ddt, J = 20.5, 7.7, 3.9 Hz, 4H).
[0171] ESI-MS (m / z): [MH-] Calculated value: 715.0096, found value: 715.0109.
[0172] Example 5
[0173] Preparation method of compound No. 170 in Table 1: (1) Synthesis of 2-fluoro-3-(N-(2-methoxyacetyl)benzamido)benzoic acid benzyl ester
[0174]
[0175] 3-Benzamido-2-fluorobenzoic acid benzyl ester (3.00 g, 8.59 mmol) was dissolved in ultra-dry tetrahydrofuran, sodium hydride (0.41 g, 17.18 mmol) was added in batches under ice bath, methoxyacetyl chloride (2.80 g, 25.77 mmol) was added after stirring for 30 min, and the mixture was heated to room temperature for reaction for 2.5 h-3.5 h. After the reaction was completed, it was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, and then spin-dried, and refined by silica gel column chromatography to obtain a product as a pink oily viscous liquid (2.54 g, yield 70.17%).
[0176] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 7.87 (dd, J = 10.5, 4.0 Hz, 1H), 7.74 (t, J = 6.6 Hz, 1H), 7.58-7.54 (m, 2H), 7.50-7.34 (m, 8H), 7.32 (t, J = 7.9 Hz, 1H), 5.35 (s, 2H), 4.50 (s, 2H), 3.32 (s, 3H).
[0177] ESI-MS (m / z): [M+Na + ]Theoretical value: 444.1223, measured value: 444.1211.
[0178] (2) Synthesis of 2-fluoro-3-(N-(2-methoxyacetyl)benzamido)benzoic acid
[0179]
[0180] Benzyl 2-fluoro-3-(N-(2-methoxyacetyl)benzamido)benzoate (3.00 g, 7.12 mmol) was dissolved in ethyl acetate, 0.60 g of 5% palladium carbon (55% water) was added, hydrogen was introduced, and the reaction was continued for 24 h. After the reaction was completed, the palladium carbon was filtered off and dried to obtain a white solid (1.25 g, yield 52.97%).
[0181] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 13.16 (s, 1H), 7.82 (t, J = 6.7 Hz, 1H), 7.67 (t, J = 6.9 Hz, 1H), 7.57 (d, J = 6.1 Hz, 2H), 7.48 (t, J = 7.4 Hz, 1H), 7.39 (t, J = 7.6 Hz, 2H), 7.27 (t, J = 7.9 Hz, 1H), 4.50 (s, 2H), 3.33 (s, 3H).
[0182] ESI-MS (m / z): [MH-] Calculated value: 330.0783, found value: 330.0788.
[0183] (3) Synthesis of 2-fluoro-3-(N-(2-methoxyacetyl)benzamide)-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide
[0184]
[0185] Dissolve 2-fluoro-3-(N-(2-methoxyacetyl)benzamido)benzoic acid (1.00 g, 3.02 mmol) in ultra-dry dichloromethane, add oxalyl chloride (0.77 g, 6.04 mmol) under ice bath, then add 1-2 drops of N,N-dimethylformamide, react at room temperature for 2h-3h, and concentrate under reduced pressure to obtain 2-fluoro-3-(N-(2-methoxyacetyl)benzamido)benzoyl chloride. Dissolve 2-fluoro-3-(N-(2-methoxyacetyl)benzamido)benzoyl chloride in acetonitrile, heat to 50°C-60°C, then add 4-(perfluoropropane-2-yl)-2-(trifluoromethyl)aniline (0.99 g, 3.02 mmol). Maintain the temperature until the reaction is complete. After concentration under reduced pressure, purify by silica gel column chromatography to obtain a white solid (1.08 g, yield 55.67%).
[0186] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.47 (s, 1H), 8.12 (d, J = 8.4 Hz, 1H), 7.99 (d, J = 8.6 Hz, 1H), 7.94 (s, 1H), 7.70 (dd, J = 13.2, 6.7 Hz, 2H), 7.63 (d, J = 7.3 Hz, 2H), 7.52 (t, J = 7.4 Hz, 1H), 7.45-7.35 (m, 3H), 4.49 (s, 2H), 3.33 (s, 3H).
[0187] ESI-MS (m / z): [MH-] Calculated value: 641.0940, found value: 641.0948.
[0188] Example 6
[0189] Preparation method of compound No. 171 in Table 1:
[0190]
[0191] 2-Fluoro-3-(N-(2-methoxyacetyl)benzamide)-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide (1.00 g, 1.56 mmol) was dissolved in acetonitrile, sodium hydroxide (0.09 g, 2.34 mmol) was added, and the mixture was stirred for 10 min under ice bath, and N-bromosuccinimide (0.56 g, 3.12 mmol) was added, and the mixture was reacted for 2.5 h to 3.5 h. After the reaction, the sodium hydroxide was filtered off, the mixture was spin-dried, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution and saturated sodium sulfite solution in a ratio of one, and saturated sodium chloride solution in sequence, and the mixture was dried over anhydrous sodium sulfate and spin-dried to obtain the product as a white solid (0.71 g, yield 62.83%).
[0192] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.78 (s, 1H), 8.43 (s, 1H), 7.98 (s, 1H), 7.74-7.66 (m, 2H), 7.62 (d, J = 7.3 Hz, 2H), 7.52 (t, J = 7.4 Hz, 1H), 7.40 (dt, J = 13.5, 7.8 Hz, 3H), 4.49 (s, 2H), 3.33 (s, 3H).
[0193] ESI-MS (m / z): [MH-] Calculated value: 719.0045, found value: 719.0054.
[0194] Example 7
[0195] Preparation method of compound No. 491 in Table 1: (1) Synthesis of methyl 2-fluoro-3-(4-fluorobenzamido)benzoate
[0196]
[0197] 3-amino-2-fluorobenzoic acid methyl ester (3.00 g, 17.74 mmol) was added to a reaction flask, dissolved with dichloromethane, pyridine (3.16 g, 39.92 mmol) was added, and p-fluorobenzoyl chloride (2.81 g, 17.74 mmol) was added dropwise under an ice bath. After the reaction was completed, it was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, and then spin-dried to obtain the product as a pink solid (4.65 g, yield 89.94%).
[0198] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.28 (s, 1H), 8.12-8.02 (m, 2H), 7.90-7.82 (m, 1H), 7.81-7.69 (m, 1H), 7.46-7.28 (m, 3H), 3.88 (s, 3H).
[0199] ESI-MS (m / z): [MH-] Calculated value: 290.0634, found value: 290.0636.
[0200] (2) Synthesis of 2-fluoro-3-(4-fluorobenzamido)benzoic acid
[0201]
[0202] Method 1: Add methyl 2-fluoro-3-(4-fluorobenzamido)benzoate (3.00 g, 10.30 mmol) to a mixture of 5% potassium hydroxide: methanol = 1:1 by volume, and hydrolyze at 25°C-35°C for 3h-4h. After the reaction is completed, add dilute hydrochloric acid to acidify, and solid precipitates. Filter and rinse with distilled water several times and then dry to obtain the product as a light pink solid (2.66 g, yield 93.01%).
[0203] Method 2: Dissolve 3-amino-2-fluorobenzoic acid (3.00 g, 19.34 mmol) in saturated sodium carbonate solution, dissolve p-fluorobenzoyl chloride (3.37 g, 21.27 mmol) in ethyl acetate and add, react overnight, acidify the inorganic phase with dilute hydrochloric acid, solid precipitates, filter and rinse with distilled water several times and dry to obtain the product as a light pink solid (2.75 g, yield 51.31%).
[0204] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 13.31 (s, 1H), 10.25 (s, 1H), 8.11-8.04 (m, 2H), 7.86-7.79 (m, 1H), 7.77-7.69 (m, 1H), 7.44-7.28 (m, 3H).
[0205] ESI-MS (m / z): [MH-] Calculated value: 276.0478, found value: 276.0481.
[0206] (3) Synthesis of Benzyl 2-Fluoro-3-(4-fluorobenzamido)benzoate
[0207]
[0208] 2-Fluoro-3-(4-fluorobenzamido)benzoic acid (3.00 g, 10.82 mmol) and thionyl chloride (10 ml) were added to the reaction flask, stirred for reaction at reflux for 3 h-4 h, and concentrated under reduced pressure to obtain 2-Fluoro-3-(4-fluorobenzamido)benzoyl chloride. 2-Fluoro-3-(4-fluorobenzamido)benzoyl chloride and pyridine (1.28 g, 16.23 mmol) were added to a solution of benzyl alcohol (1.76 g, 16.23 mmol) in acetonitrile (20 ml), and the reaction was continued overnight. The product was washed with saturated sodium carbonate solution, dilute hydrochloric acid (2 mol / L), and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, and then spin-dried to obtain the product as a light pink solid (3.52 g, yield 88.66%).
[0209] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.30 (s, 1H), 8.12-8.04 (m, 2H), 7.89 (t, J = 7.4 Hz, 1H), 7.79 (dd, J = 10.3, 3.9 Hz, 1H), 7.53-7.46 (m, 2H), 7.45-7.31 (m, 6H), 5.39 (s, 2H).
[0210] ESI-MS (m / z): [MH-] Calculated value: 366.0947, found value: 366.0946.
[0211] (4) Synthesis of 3-(N-(cyclopropanecarbonyl)-4-fluorobenzamido)-2-fluorobenzoic acid benzyl ester
[0212]
[0213] Benzyl 2-fluoro-3-(4-fluorobenzamido)benzoate (3.00 g, 8.17 mmol) was dissolved in dichloromethane, 4-dimethylaminopyridine (0.10 g, 0.82 mmol) and triethylamine (1.65 g, 16.34 mmol) were added, and cyclopropylcarbonyl chloride (1.28 g, 12.26 mmol) was added after stirring for a while, and the mixture was reacted at 35°C-39°C, and the reaction was detected by spot plate detection until the reaction was completed. After the reaction was completed, the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, and then spin-dried to obtain a product as a pink oily viscous liquid (3.14 g, yield 88.20%).
[0214] The hydrogen nuclear magnetic resonance spectrum (600 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 8.01-7.92 (m, 1H), 7.88-7.81 (m, 1H), 7.80-7.72 (m, 2H), 7.50-7.25 (m, 8H), 5.37 (s, 2H), 1.93-1.83 (m, 1H), 1.00-0.87 (m, 4H).
[0215] ESI-MS (m / z): [M+Na + ]Theoretical value: 458.1180, measured value: 458.1177.
[0216] (5) Synthesis of 3-(N-(cyclopropanecarbonyl)-4-fluorobenzamide)-2-fluorobenzoic acid
[0217]
[0218] Benzyl 3-(N-(cyclopropanecarbonyl)-4-fluorobenzamido)-2-fluorobenzoate (3.00 g, 6.89 mmol) was dissolved in ethyl acetate, 0.60 g of 5% palladium carbon (55% water) was added, hydrogen was introduced, and the reaction was continued for 24 h. After the reaction was completed, the palladium carbon was filtered off and dried to obtain a white solid (1.21 g, yield 50.84%).
[0219] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 13.41 (s, 1H), 7.89 (dd, J = 10.5, 4.0 Hz, 1H), 7.80-7.73 (m, 3H), 7.34 (dt, J = 17.6, 8.3 Hz, 3H), 1.92-1.85 (m, 1H), 0.99-0.88 (m, 4H).
[0220] ESI-MS (m / z): [MH-] Calculated value: 344.0740, Found value: 344.0740.
[0221] (6) Synthesis of 3-(N-(cyclopropanecarbonyl)-4-fluorobenzamide)-2-fluoro-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide
[0222]
[0223] Dissolve 3-(N-(cyclopropanecarbonyl)-4-fluorobenzamide)-2-fluorobenzoic acid (1.00 g, 2.90 mmol) in ultra-dry dichloromethane, add oxalyl chloride (0.74 g, 5.80 mmol) under ice bath, then add 1-2 drops of N,N-dimethylformamide, react at room temperature for 2h-3h, and concentrate under reduced pressure to obtain 3-(N-(cyclopropanecarbonyl)-4-fluorobenzamide)-2-fluorobenzoyl chloride. Dissolve 3-(N-(cyclopropanecarbonyl)-4-fluorobenzamide)-2-fluorobenzoyl chloride in acetonitrile, heat to 50℃-60℃, then add 4-(perfluoropropane-2-yl)-2-(trifluoromethyl)aniline (0.95 g, 2.90 mmol). Maintain the temperature until the reaction is complete. After concentration under reduced pressure, the residue was purified by silica gel column chromatography to obtain a white solid (1.01 g, yield 53.16%).
[0224] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.52 (s, 1H), 8.12 (d, J = 8.7 Hz, 1H), 8.00 (d, J = 8.6 Hz, 1H), 7.94 (s, 1H), 7.84-7.75 (m, 4H), 7.47 (t, J = 7.9 Hz, 1H), 7.33 (t, J = 8.8 Hz, 2H), 1.91-1.83 (m, 1H), 1.020.90 (m, 4H).
[0225] ESI-MS (m / z): [MH-] Calculated value: 655.0897, found value: 655.0904.
[0226] Example 8
[0227] Preparation method of compound No. 492 in Table 1:
[0228]
[0229] 3-(N-(cyclopropanecarbonyl)-4-fluorobenzamide)-2-fluoro-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide (1.00 g, 1.52 mmol) was dissolved in acetonitrile, sodium hydroxide (0.09 g, 2.28 mmol) was added, and the mixture was stirred for 10 min under an ice bath, and N-bromosuccinimide (0.54 g, 3.04 mmol) was added, and the mixture was reacted for 2.5 h to 3.5 h. After the reaction, the sodium hydroxide was filtered off, the mixture was spin-dried, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution and saturated sodium sulfite solution in a ratio of one, and saturated sodium chloride solution in sequence, and the mixture was dried over anhydrous sodium sulfate and spin-dried to obtain the product as a white solid (0.65 g, yield 58.04%).
[0230] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.84 (s, 1H), 8.43 (s, 1H), 7.97 (s, 1H), 7.85-7.70 (m, 4H), 7.53-7.44 (t, 1H), 7.34 (t, J = 8.8 Hz, 2H), 1.90-1.82 (m, 1H), 0.95 (ddd, J = 11.2, 7.4, 3.3 Hz, 4H).
[0231] ESI-MS (m / z): [MH-] Calculated value: 733.0002, found value: 733.0013.
[0232] Example 9
[0233] Preparation method of compound No. 506 in Table 1: (1) Synthesis of 2-fluoro-3-(4-fluoro-N-(2-methoxyacetyl)benzamido)benzoic acid benzyl ester
[0234]
[0235] Benzyl 2-fluoro-3-(4-fluorobenzamido)benzoate (3.00 g, 8.17 mmol) was dissolved in ultra-dry tetrahydrofuran, sodium hydride (0.39 g, 16.34 mmol) was added in batches under ice bath, methoxyacetyl chloride (2.66 g, 24.51 mmol) was added after stirring for 30 min, and the mixture was heated to room temperature for reaction for 2.5 h-3.5 h. After the reaction was completed, it was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, and then spin-dried, and refined by silica gel column chromatography to obtain a product as a pink oily viscous liquid (2.57 g, yield 71.59%).
[0236] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 7.93-7.86 (m, 1H), 7.79-7.72 (m, 1H), 7.69-7.62 (m, 2H), 7.48-7.31 (m, 6H), 7.24 (t, J = 8.8 Hz, 2H), 5.35 (s, 2H), 4.54-4.43 (m, 2H), 3.32 (s, 3H).
[0237] ESI-MS (m / z): [M+Na + ]Theoretical value: 462.1129, measured value: 462.1120.
[0238] (2) Synthesis of 2-fluoro-3-(4-fluoro-N-(2-methoxyacetyl)benzamido)benzoic acid
[0239]
[0240] Benzyl 2-fluoro-3-(4-fluoro-N-(2-methoxyacetyl)benzamido)benzoate (3.00 g, 6.83 mmol) was dissolved in ethyl acetate, 0.60 g of 5% palladium carbon (55% water) was added, hydrogen was introduced, and the reaction was continued for 24 h. After the reaction was completed, the palladium carbon was filtered off and dried to obtain a white solid (1.28 g, yield 53.56%).
[0241] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 13.42 (s, 1H), 7.85 (t, J = 6.8 Hz, 1H), 7.72-7.63 (m, 3H), 7.28 (ddd, J = 24.3, 12.7, 5.9 Hz, 3H), 4.48 (s, 2H), 3.33 (s, 3H).
[0242] ESI-MS (m / z): [MH-] Calculated value: 348.0689, found value: 348.0694.
[0243] (3) Synthesis of 2-fluoro-3-(4-fluoro-N-(2-methoxyacetyl)benzamide)-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide
[0244]
[0245] Dissolve 2-fluoro-3-(4-fluoro-N-(2-methoxyacetyl)benzamide)benzoic acid (1.00 g, 2.86 mmol) in ultra-dry dichloromethane, add oxalyl chloride (0.73 g, 5.72 mmol) under ice bath, then add 1-2 drops of N,N-dimethylformamide, react at room temperature for 2h-3h, and concentrate under reduced pressure to obtain 2-fluoro-3-(4-fluoro-N-(2-methoxyacetyl)benzamide)benzoyl chloride. Dissolve 2-fluoro-3-(4-fluoro-N-(2-methoxyacetyl)benzamide)benzoyl chloride in acetonitrile, heat to 50°C-60°C, and add 4-(perfluoropropane-2-yl)-2-(trifluoromethyl)aniline (0.94 g, 2.86 mmol). Maintain the temperature until the reaction is complete. After concentration under reduced pressure, the residue was purified by silica gel column chromatography to obtain a white solid (1.11 g, yield 58.73%).
[0246] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.48 (s, 1H), 8.12 (d, J = 8.9 Hz, 1H), 7.99 (d, J = 8.6 Hz, 1H), 7.95 (s, 1H), 7.75-7.67 (m, 4H), 7.40 (t, J = 7.8 Hz, 1H), 7.30-7.23 (t, 2H), 4.47 (s, 2H), 3.33 (s, 3H).
[0247] ESI-MS (m / z): [MH-] Calculated value: 659.0846, found value: 659.0853.
[0248] Example 10
[0249] Preparation method of compound No. 507 in Table 1:
[0250]
[0251] 2-Fluoro-3-(4-fluoro-N-(2-methoxyacetyl)benzamide)-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide (1.00 g, 1.51 mmol) was dissolved in acetonitrile, sodium hydroxide (0.09 g, 2.27 mmol) was added, and the mixture was stirred for 10 min under an ice bath, and N-bromosuccinimide (0.54 g, 3.02 mmol) was added, and the mixture was reacted for 2.5 h to 3.5 h. After the reaction, the sodium hydroxide was filtered off, the mixture was spin-dried, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution and saturated sodium sulfite solution in a ratio of one, and saturated sodium chloride solution in sequence, and the mixture was dried over anhydrous sodium sulfate and spin-dried to obtain the product as a white solid (0.73 g, yield 65.18%).
[0252] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.78 (s, 1H), 8.44 (s, 1H), 7.97 (s, 1H), 7.77-7.67 (m, 4H), 7.42 (t, J = 7.6 Hz, 1H), 7.27 (t, J = 8.8 Hz, 2H), 4.47 (s, 2H), 3.33 (s, 3H).
[0253] ESI-MS (m / z): [MH-] Calculated value: 736.9951, found value: 736.9953.
[0254] Embodiment 11
[0255] Preparation method of compound No. 971 in Table 1: (1) Synthesis of 2-fluoro-N-(2-methyl-4-(perfluoropropane-2-yl)phenyl)-3-nitrobenzamide
[0256]
[0257] Add 2-fluoro-3-nitrobenzoic acid (3.00g, 16.21mmol) and thionyl chloride (10ml) into the reaction flask, stir the reaction under reflux for 2h, concentrate under reduced pressure to obtain 2-fluoro-3-nitrobenzoyl chloride. 2-fluoro-3-nitrobenzoyl chloride and pyridine (1.76g, 22.39mmol) are added to a dichloromethane (20ml) solution of 4-(perfluoropropane-2-yl)-2-methylaniline (2.94g, 10.69mmol), and the reaction is stopped after 5 hours of reaction at room temperature. Wash with dilute hydrochloric acid (2mol / L), saturated potassium carbonate solution, and saturated sodium chloride solution, and spin-dry after anhydrous sodium sulfate drying to obtain the product as a light yellow solid (4.50g, 95.23% yield).
[0258] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.36 (s, 1H), 8.33 (t, J = 7.1 Hz, 1H), 8.12 (t, J = 6.1 Hz, 1H), 7.87 (d, J = 8.4 Hz, 1H), 7.63-7.54 (m, 3H), 2.40 (s, 3H).
[0259] ESI-MS (m / z): [MH-] Calculated value: 441.0490, found value: 441.0491.
[0260] (2) Synthesis of 3-amino-2-fluoro-N-(2-methyl-4-(perfluoropropane-2-yl)phenyl)benzamide
[0261]
[0262] N-(2-bromo-6-methyl-4-(perfluoropropane-2-yl)phenyl)-2-fluoro-3-nitrobenzamide (3.00 g, 6.78 mmol) was dissolved in ethanol (20 ml), and dihydrated stannous chloride (6.12 g, 27.12 mmol) was added in batches, and the temperature was raised to 60°C for 4 hours. The reaction solution was dried under reduced pressure, dissolved with ethyl acetate solution, and saturated sodium carbonate solution was added to generate solids. The solids were filtered off, and the organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and dried under reduced pressure to obtain a brown solid (2.02 g, yield 72.14%).
[0263] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 9.91 (s, 1H), 7.84 (d, J = 8.5 Hz, 1H), 7.59-7.48 (m, 2H), 6.99 (t, J = 7.7 Hz, 1H), 6.92 (td, J = 8.2, 1.7 Hz, 1H), 6.86-6.79 (m, 1H), 5.40 (s, 2H), 2.38 (s, 3H).
[0264] (3) Synthesis of 2-chloro-N-(2-fluoro-3-((2-methyl-4-(perfluoropropane-2-yl)phenyl)carbamoyl)phenyl)nicotinamide
[0265]
[0266] 3-Amino-2-fluoro-N-(2-methyl-4-(perfluoropropane-2-yl)phenyl)benzamide (3.00 g, 7.28 mmol) was dissolved in acetonitrile, 2-chloronicotinoyl chloride (1.28 g, 7.28 mmol) was added, and the mixture was reacted at 80° C. for 2 h. The crude product was spin-dried and was not further treated to obtain a light yellow solid (3.23 g, yield 80.35%).
[0267] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.72 (s, 1H), 10.16 (s, 1H), 8.55 (dd, J = 4.8, 1.9 Hz, 1H), 8.17-8.05 (m, 2H), 7.86 (d, 1H), 7.57 (dt, J = 13.8, 6.8 Hz, 4H), 7.39 (t, J = 7.9 Hz, 1H), 2.40 (s, 3H).
[0268] (4) Synthesis of 2-chloro-N-(cyclopropylcarbonyl)-N-(2-fluoro-3-((2-methyl-4-(perfluoropropane-2-yl)phenyl)carbamoyl)phenyl)nicotinamide
[0269]
[0270] 2-Chloro-N-(2-fluoro-3-((2-methyl-4-(perfluoropropane-2-yl)phenyl)carbamoyl)phenyl)nicotinamide (1.00 g, 1.81 mmol) was dissolved in dichloromethane, triethylamine (0.28 g, 2.72 mmol) was added, and then cyclopropylcarbonyl chloride (0.21 g, 1.99 mmol) was added, and the reaction was carried out at room temperature for 4-5 hours. The reaction solution was washed with dilute hydrochloric acid (2 mol / L), saturated sodium bicarbonate, saturated brine, and dried over anhydrous sodium sulfate, and then dried under reduced pressure. The residue was purified by silica gel column chromatography to obtain a white solid (0.36 g, 32.14%).
[0271] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.26 (s, 1H), 8.50 (dd, J = 4.8, 1.9 Hz, 1H), 8.08 (dd, J = 7.6, 1.9 Hz, 1H), 7.86 (ddd, J = 17.1, 14.4, 7.4 Hz, 3H), 7.55 (dt, J = 13.0, 9.7 Hz, 4H), 2.39 (s, 3H), 1.76-1.66 (m, 1H), 0.98-0.88 (m, 4H).
[0272] ESI-MS (m / z): [MH-] Calculated value: 618.0836, Found value: 618.0836.
[0273] Example 12
[0274] Preparation method of compound No. 978 in Table 1: (1) Synthesis of 3-(2-chloronicotinamide)-2-fluorobenzoic acid
[0275]
[0276] 3-Amino-2-fluorobenzoic acid (3.00 g, 19.34 mmol) was dissolved in saturated sodium carbonate solution, 2-chloronicotinoyl chloride (3.74 g, 21.27 mmol) was dissolved in ethyl acetate and added, the reaction was allowed to proceed overnight, the inorganic phase was acidified with dilute hydrochloric acid, a solid precipitated, the solid was filtered, washed with distilled water several times and dried to obtain the product as a light pink solid (2.65 g, yield 46.49%).
[0277] The hydrogen nuclear magnetic resonance spectrum (600 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 13.39 (s, 1H), 10.65 (s, 1H), 8.56 (dd, J = 4.8, 1.8 Hz, 1H), 8.16-8.06 (m, 2H), 7.72 (t, J = 6.5 Hz, 1H), 7.58 (dt, J = 10.8, 5.4 Hz, 1H), 7.35 (t, J = 7.9 Hz, 1H).
[0278] ESI-MS (m / z): [MH-] Calculated value: 293.0135, found value: 293.0136.
[0279] (2) Synthesis of Benzyl 3-(2-Chloronicotinamide)-2-Fluorobenzoate
[0280]
[0281] 3-(2-chloronicotinamide)-2-fluorobenzoic acid (3.00 g, 10.18 mmol) and dichlorothionyl (10 ml) were added to the reaction bottle, stirred for reaction under reflux for 3 h-4 h, and concentrated under reduced pressure to obtain 3-(2-chloronicotinamide)-2-fluorobenzoyl chloride. 3-(2-chloronicotinamide)-2-fluorobenzoyl chloride and pyridine (1.21 g, 15.27 mmol) were added to a solution of benzyl alcohol (1.65 g, 15.27 mmol) in acetonitrile (20 ml), and the reaction was continued overnight. The product was washed with saturated sodium carbonate solution, dilute hydrochloric acid (2 mol / L), and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, and then spin-dried to obtain the product as a lavender solid (3.58 g, yield 91.33%).
[0282] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.68 (s, 1H), 8.54 (dd, J = 4.8, 1.7 Hz, 1H), 8.17 (t, J = 6.9 Hz, 1H), 8.09 (dd, J = 7.5, 1.7 Hz, 1H), 7.76 (t, J = 6.5 Hz, 1H), 7.60-7.54 (m, 1H), 7.48 (d, J = 7.3 Hz, 2H), 7.39 (dt, J = 15.8, 7.2 Hz, 4H), 5.39 (s, 2H).
[0283] ESI-MS (m / z): [MH-] Calculated value: 383.0604, found value: 383.0607.
[0284] (3) Synthesis of 3-(2-chloro-N-(cyclopropanecarbonyl)nicotinamide)-2-fluorobenzoic acid benzyl ester
[0285]
[0286] 3-(2-chloronicotinamide)-2-fluorobenzoic acid benzyl ester (3.00g, 7.80mmol) was dissolved in dichloromethane, 4-dimethylaminopyridine (0.10g, 0.78mmol) and triethylamine (1.58g, 15.60mmol) were added, and cyclopropylcarbonyl chloride (0.98g, 9.36mmol) was added after stirring for a while, and the reaction was carried out at 35°C-39°C, and the plate was detected until the reaction was completed. After the reaction was completed, it was washed with dilute hydrochloric acid (2mol / L), saturated sodium carbonate solution, and saturated sodium chloride solution in sequence, dried over anhydrous sodium sulfate, and then spin-dried to obtain a product as a pink oily viscous liquid (3.12g, yield 88.39%).
[0287] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 8.49 (dd, J = 4.8, 1.8 Hz, 1H), 8.07 (td, J = 7.9, 1.6 Hz, 2H), 7.97 (dd, J = 10.5, 4.1 Hz, 1H), 7.58-7.47 (m, 4H), 7.42 (t, J = 7.5 Hz, 2H), 7.38 (d, J = 7.2 Hz, 1H), 5.41 (s, 2H), 1.70 (ddd, J = 12.4, 7.6, 4.7 Hz, 1H), 0.96-0.84 (m, 4H).
[0288] ESI-MS (m / z): [M+Na + ]Theoretical value: 475.0837, measured value: 475.0827.
[0289] (4) Synthesis of 3-(2-chloro-N-(cyclopropanecarbonyl)nicotinamide)-2-fluorobenzoic acid
[0290]
[0291] Benzyl 3-(2-chloro-N-(cyclopropanecarbonyl)nicotinamide)-2-fluorobenzoate (3.00 g, 6.62 mmol) was dissolved in ethyl acetate, 0.60 g of 5% palladium carbon (55% water) was added, hydrogen was introduced, and the reaction was continued for 24 hours. After the reaction was completed, the palladium carbon was filtered off and dried to obtain a light yellow solid (1.97 g, yield 82.08%).
[0292] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 13.17 (s, 1H), 8.48 (dd, J = 4.8, 1.8 Hz, 1H), 8.06 (dd, J = 7.6, 1.7 Hz, 1H), 8.00 (dd, J = 10.5, 4.0 Hz, 1H), 7.90 (t, J = 6.6 Hz, 1H), 7.54 (dd, J = 7.6, 4.8 Hz, 1H), 7.47 (t, J = 7.9 Hz, 1H), 1.72-1.64 (m, 1H), 0.94-0.87 (m, 4H).
[0293] ESI-MS (m / z): [MH-] Calculated value: 361.0397, found value: 361.0398.
[0294] (5) Synthesis of 2-chloro-N-(cyclopropanecarbonyl)-N-(2-fluoro-3-((4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)carbamoyl)phenyl)nicotinamide
[0295]
[0296] Dissolve 3-(2-chloro-N-(cyclopropanecarbonyl)nicotinamide)-2-fluorobenzoic acid (1.00 g, 2.76 mmol) in ultra-dry dichloromethane, add oxalyl chloride (0.70 g, 5.52 mmol) under ice bath, then add 1-2 drops of N,N-dimethylformamide, react at room temperature for 2h-3h, and concentrate under reduced pressure to obtain 3-(2-chloro-N-(cyclopropanecarbonyl)nicotinamide)-2-fluorobenzoyl chloride. Dissolve 3-(2-chloro-N-(cyclopropanecarbonyl)nicotinamide)-2-fluorobenzoyl chloride in acetonitrile, heat to 50℃-60℃, and add 4-(perfluoropropane-2-yl)-2-(trifluoromethyl)aniline (0.91 g, 2.76 mmol). Maintain the temperature until the reaction is complete. After concentration under reduced pressure, the residue was purified by silica gel column chromatography to obtain a white solid (1.02 g, yield 54.84%).
[0297] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.58 (s, 1H), 8.50 (dd, J = 4.8, 1.8 Hz, 1H), 8.14 (d, J = 8.6 Hz, 1H), 8.08 (dd, J = 7.6, 1.8 Hz, 1H), 8.03 (d, J = 8.6 Hz, 1H), 7.95 (s, 1H), 7.92-7.85 (m, 2H), 7.59-7.52 (m, 2H), 1.75-1.67 (m, 1H), 0.97-0.89 (m, 4H).
[0298] ESI-MS (m / z): [MH-] Calculated value: 672.0554, found value: 672.0558.
[0299] Embodiment 13
[0300] Preparation method of compound No. 979 in Table 1:
[0301]
[0302] 2-Chloro-N-(cyclopropanecarbonyl)-N-(2-fluoro-3-((4-(perfluoropropane-2-yl)-2-(trifluoromethyl))carbamoyl)phenyl)nicotinamide (1.00 g, 1.48 mmol) was dissolved in acetonitrile, sodium hydroxide (0.09 g, 2.22 mmol) was added, and the mixture was stirred for 10 min under ice bath, and N-bromosuccinimide (0.53 g, 2.96 mmol) was added, and the mixture was reacted for 2.5 h-3.5 h. After the reaction, the sodium hydroxide was filtered off, the mixture was spin-dried, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution and saturated sodium sulfite solution in a ratio of 1:1, and saturated sodium chloride solution in sequence, and the mixture was dried over anhydrous sodium sulfate and spin-dried to obtain the product as a light yellow solid (0.59 g, yield 53.15%).
[0303] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.90 (s, 1H), 8.50 (dd, J = 4.8, 1.8 Hz, 1H), 8.45 (s, 1H), 8.09 (dt, J = 6.3, 3.2 Hz, 1H), 7.98 (s, 1H), 7.91 (dd, J = 10.7, 4.2 Hz, 1H), 7.85 (t, J = 6.4 Hz, 1H), 7.61-7.51 (m, 2H), 1.71 (d, J = 5.3 Hz, 1H), 0.93 (d, J = 7.4 Hz, 4H).
[0304] ESI-MS (m / z): [MH-] Calculated value: 751.9638, found value: 751.9639.
[0305] Embodiment 14
[0306] Preparation method of compound No. 1121 in Table 1: (1) Synthesis of 2-fluoro-3-nitro-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide
[0307]
[0308] Add 2-fluoro-3-nitrobenzoic acid (1.66 g, 8.97 mmol) and thionyl chloride (10 ml) to the reaction flask, stir and react under reflux for 2 h, and concentrate under reduced pressure to obtain 2-fluoro-3-nitrobenzoyl chloride. Add 2-fluoro-3-nitrobenzoyl chloride to a solution of 4-(perfluoropropane-2-yl)-2-(trifluoromethyl)aniline (2.36 g, 7.17 mmol) in acetonitrile (20 ml), heat to 80 ° C and react for 8 h. Wash with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated sodium chloride solution, dry over anhydrous sodium sulfate, and spin dry to obtain the product as a white solid (3.20 g, yield 90.16%)
[0309] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.74 (s, 1H), 8.37-8.32 (m, 1H), 8.15-8.03 (m, 3H), 7.94 (s, 1H), 7.61 (t, J = 7.9 Hz, 1H).
[0310] ESI-MS (m / z): [MH-] Calculated value: 495.0208, found value: 495.0203.
[0311] (2) Synthesis of N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-2-fluoro-3-nitrobenzamide
[0312]
[0313] 2-Fluoro-3-nitro-N-(4-(perfluoropropane-2-yl)-2-(trifluoromethyl)phenyl)benzamide (2.00 g, 4.03 mmol), sodium hydroxide (0.30 g, 7.50 mmol) and acetonitrile (10 ml) were added to the reaction flask, and N-bromosuccinimide (0.92 g, 5.17 mmol) was added in portions. The reaction was stopped after reacting at room temperature for 7 h. The reaction solution was spin-dried under reduced pressure, dissolved with ethyl acetate solution, washed with saturated sodium sulfite, saturated sodium bicarbonate solution, and saturated sodium chloride solution, dried over anhydrous sodium sulfate, and spin-dried to obtain the product as a white solid (1.76 g, yield 76.35%).
[0314] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 11.13 (s, 1H), 8.45 (d, J = 1.1 Hz, 1H), 8.41-8.35 (m, 1H), 8.06 (ddd, J = 7.5, 5.9, 1.6 Hz, 1H), 7.98 (s, 1H), 7.65 (t, J = 8.0 Hz, 1H).
[0315] ESI-MS (m / z): [MH-] Calculated value: 572.9313, found value: 572.9318.
[0316] (3) Synthesis of 3-amino-N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-2-fluorobenzamide
[0317]
[0318] N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-2-fluoro-3-nitrobenzamide (1.76 g, 3.07 mmol) was dissolved in ethanol (20 ml), and dihydrated stannous chloride (2.76 g, 12.26 mmol) was added in batches, and the temperature was raised to 60° C. for 4 h. The reaction solution was spin-dried under reduced pressure, dissolved with ethyl acetate solution, washed with 10% sodium hydroxide aqueous solution, and the solid was filtered off. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and then spin-dried under reduced pressure to obtain a yellow solid (1.20 g, yield 71.99%).
[0319] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.74 (s, 1H), 8.37-8.32 (m, 1H), 8.15-8.03 (m, 4H), 7.94 (s, 1H), 7.61 (t, J = 7.9 Hz, 1H).
[0320] ESI-MS (m / z): [MH-] Calculated value: 542.9571, found value: 542.9574.
[0321] (4) Synthesis of N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-2-fluoro-3-(4-fluorobenzamido)benzamide
[0322]
[0323] 3-amino-N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-2-fluorobenzamide (1.20 g, 2.21 mmol) was added to 10 ml of acetonitrile, the temperature was raised to 80°C, p-fluorobenzoyl chloride (0.34 g, 2.14 mmol) was added dropwise, and the reaction was continued for 2 h. The reaction solution was dried under reduced pressure, dissolved with ethyl acetate solution, washed with saturated sodium carbonate and saturated brine, dried over anhydrous sodium sulfate, dried under reduced pressure, and the residue was purified by column chromatography (eluent: n-hexane: ethyl acetate = 10:1) to obtain a white solid (1.40 g, yield 95.27%).
[0324] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.78 (s, 1H), 10.34 (s, 1H), 8.44 (s, 1H), 8.13-8.07 (m, 2H), 7.98 (s, 1H), 7.84 (t, J = 7.5 Hz, 1H), 7.62-7.57 (m, 1H), 7.44-7.36 (m, 3H).
[0325] ESI-MS (m / z): [MH-] Calculated value: 664.9739, found value: 664.9747.
[0326] (5) Synthesis of N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-N-(cyclopropanecarbonyl)-2-fluoro-3-(4-fluorobenzamido)benzamide
[0327]
[0328] N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-2-fluoro-3-(4-fluorobenzamide)benzamide (1.00 g, 1.50 mmol) was dissolved in dichloromethane (10 ml), triethylamine (0.23 g, 2.31 mmol) was added, and the mixture was stirred at room temperature for 10 min, and cyclopropaneyl chloride (0.18 g, 1.72 mmol) was added dropwise, and the mixture was reacted overnight at room temperature. The reaction solution was washed with saturated sodium bicarbonate and saturated brine, dried over anhydrous sodium sulfate, and dried under reduced pressure. The residue was purified by column chromatography (eluent: n-hexane: ethyl acetate = 10:1) to obtain a white solid (0.49 g, 44.57%).
[0329] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.31 (s, 1H), 8.61 (s, 1H), 8.09 (dd, J = 7.7, 4.2 Hz, 3H), 7.83 (t, J = 6.7 Hz, 1H), 7.45-7.33 (m, 4H), 1.42 (ddd, J = 12.1, 7.8, 4.4 Hz, 1H), 0.99-0.92 (m, 2H), 0.91-0.84 (m, 2H).
[0330] ESI-MS (m / z): [MH-] Calculated value: 733.0002, found value: 733.0012.
[0331] (6) Synthesis of N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-N-(cyclopropanecarbonyl)-3-(N-(cyclopropanecarbonyl)-4-fluorobenzamide)-2-fluorobenzamide
[0332]
[0333] N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-N-(cyclopropanecarbonyl)-2-fluoro-3-(4-fluorobenzamide)benzamide (1.00 g, 1.36 mmol) was dissolved in ultra-dry tetrahydrofuran, sodium hydride (0.07 g, 2.72 mmol) was added in batches, stirred for 30 min under ice bath, cyclopropylcarbonyl chloride (0.21 g, 2.04 mmol) was added, and the mixture was reacted at room temperature for 2.5 h-3.5 h. After the reaction was completed, the mixture was dried by rotation, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated brine in sequence, dried over anhydrous sodium sulfate, dried under reduced pressure by rotation, and purified by silica gel column chromatography to obtain a light pink solid (0.57 g, 52.29%).
[0334] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 8.61 (s, 1H), 8.10 (s, 1H), 7.76 (dd, J = 8.6, 5.6 Hz, 3H), 7.57 (t, J = 6.5 Hz, 1H), 7.41 (t, J = 7.9 Hz, 1H), 7.33-7.26 (m, 2H), 1.94 (ddd, J = 12.4, 7.5, 5.1 Hz, 1H), 1.44-1.34 (m, 1H), 1.01-0.86 (m, 8H).
[0335] ESI-MS (m / z): [M+Na + ]Theoretical value: 827.0214, measured value: 827.0200.
[0336] Embodiment 15
[0337] Preparation method of compound No. 1123 in Table 1:
[0338]
[0339] N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-N-(cyclopropanecarbonyl)-2-fluoro-3-(4-fluorobenzamide)benzamide (1.00 g, 1.36 mmol) was dissolved in ultra-dry tetrahydrofuran, sodium hydride (0.07 g, 2.72 mmol) was added in batches, stirred for 30 min under ice bath, acryloyl chloride (0.18 g, 2.04 mmol) was added, and the mixture was reacted at room temperature for 2.5 h-3.5 h. After the reaction was completed, the mixture was dried by rotation, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated brine in sequence, dried over anhydrous sodium sulfate, and dried under reduced pressure by rotation, and purified by silica gel column chromatography to obtain a light pink solid (0.38 g, 35.51%).
[0340] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 8.60 (s, 1H), 8.09 (s, 1H), 7.78-7.67 (m, 3H), 7.55 (t, J = 6.3 Hz, 1H), 7.38 (t, J = 7.9 Hz, 1H), 7.32-7.24 (m, 2H), 6.59 (dd, J = 16.9, 10.3 Hz, 1H), 6.35 (dd, J = 16.9, 1.5 Hz, 1H), 5.92 (dd, J = 10.3, 1.5 Hz, 1H), 1.36 (d, J = 6.5 Hz, 1H), 0.93-0.86 (m, 4H).
[0341] ESI-MS (m / z): [M+Na + ]Theoretical value: 811.0078, measured value: 811.0074.
[0342] Example 16
[0343] Preparation method of compound No. 1124 in Table 1:
[0344]
[0345] N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-N-(cyclopropanecarbonyl)-2-fluoro-3-(4-fluorobenzamide)benzamide (1.00 g, 1.36 mmol) was dissolved in ultra-dry tetrahydrofuran, sodium hydride (0.07 g, 2.72 mmol) was added in batches, stirred for 30 min under ice bath, methoxyacetyl chloride (0.22 g, 2.04 mmol) was added, and the mixture was reacted at room temperature for 2.5 h-3.5 h. After the reaction was completed, the mixture was dried by rotation, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated brine in sequence, dried over anhydrous sodium sulfate, dried under reduced pressure by rotation, and purified by silica gel column chromatography to obtain a white solid (0.61 g, 55.45%).
[0346] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 8.60 (d, J = 1.3 Hz, 1H), 8.09 (s, 1H), 7.70-7.62 (m, 3H), 7.53 (t, J = 6.4 Hz, 1H), 7.34 (t, J = 7.9 Hz, 1H), 7.25-7.18 (m, 2H), 4.49 (s, 2H), 3.34 (s, 3H), 1.35 (d, J = 4.9 Hz, 1H), 0.89 (ddd, J = 11.3, 7.6, 3.6 Hz, 4H).
[0347] ESI-MS (m / z): [M+Na+ ]Theoretical value: 829.0183, measured value: 829.0176.
[0348] Embodiment 17
[0349] Preparation method of compound No. 1141 in Table 1: (1) Synthesis of N-(3-((2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)carbamoyl)-2-fluorophenyl)-2-chloronicotinamide
[0350]
[0351] 3-amino-N-(2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)-2-fluorobenzamide (1.20 g, 2.20 mmol) was added to 5 ml of acetonitrile, the temperature was raised to 80°C, 2-chloronicotinoyl chloride (0.39 g, 2.21 mmol) was added, and the reaction was continued for 2 h. The reaction solution was dried under reduced pressure, dissolved with ethyl acetate solution, washed with saturated potassium carbonate and saturated brine, dried over anhydrous sodium sulfate, dried under reduced pressure, and the residue was purified by column chromatography (eluent: n-hexane: ethyl acetate = 10:1) to obtain a light yellow solid (1.20 g, yield 79.75%).
[0352] The H NMR spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.81 (s, 1H), 10.75 (s, 1H), 8.55 (dd, J = 4.8, 1.8 Hz, 1H), 8.44 (s, 1H), 8.17 (q, J = 7.3 Hz, 1H), 8.10 (dd, J = 7.5, 1.8 Hz, 1H), 7.98 (s, 2H), 7.61-7.52 (m, 2H), 7.43 (t, J = 7.9 Hz, 1H).
[0353] ESI-MS (m / z): [MH-] Calculated value: 683.9376, found value: 683.9371.
[0354] (2) Synthesis of N-(3-((2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)(cyclopropanecarbonyl)carbamoyl)-2-fluorophenyl)-2-chloro-N-(cyclopropanecarbonyl)nicotinamide
[0355]
[0356] N-(3-((2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)carbamoyl)-2-fluorophenyl)-2-chloronicotinamide (1.00 g, 1.46 mmol) was dissolved in acetonitrile, triethylamine (0.44 g, 4.38 mmol) was added, the temperature was raised to 60°C, cyclopropylcarbonyl chloride (0.46 g, 4.38 mmol) was added, and the reaction was continued for 2.5 h-3.5 h. After the reaction was completed, the mixture was dried by rotation, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated brine in sequence, dried over anhydrous sodium sulfate, and dried under reduced pressure by rotation, and purified by silica gel column chromatography to obtain a white solid (0.83 g, 69.17%).
[0357] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 8.62 (s, 1H), 8.48 (dd, J = 4.8, 1.9 Hz, 1H), 8.14-8.04 (m, 2H), 7.94-7.86 (m, 1H), 7.72-7.62 (m, 1H), 7.57-7.47 (m, 2H), 1.76-1.66 (m, 1H), 1.46-1.37 (m, 1H), 0.97-0.84 (m, 8H).
[0358] ESI-MS (m / z): [M+H + ]Theoretical value: 822.0051, measured value: 822.0033.
[0359] Embodiment 18
[0360] Preparation method of compound No. 1142 in Table 1:
[0361]
[0362] N-(3-((2-bromo-4-(perfluoropropane-2-yl)-6-(trifluoromethyl)phenyl)carbamoyl)-2-fluorophenyl)-2-chloronicotinamide (1.00 g, 1.46 mmol) was dissolved in acetonitrile, triethylamine (0.44 g, 4.38 mmol) was added, the temperature was raised to 60°C, acryloyl chloride (0.40 g, 4.38 mmol) was added, and the reaction was continued for 2.5-3.5 h. After the reaction was completed, the mixture was dried by rotation, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated brine in sequence, dried over anhydrous sodium sulfate, dried under reduced pressure by rotation, and purified by silica gel column chromatography to obtain a white solid (0.51 g, 43.97%).
[0363] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 8.59 (s, 1H), 8.50 (dd, J = 4.8, 1.8 Hz, 1H), 8.11 (dd, J = 7.6, 1.7 Hz, 2H), 7.86 (dd, J = 10.8, 4.3 Hz, 1H), 7.68 (t, J = 6.5 Hz, 1H), 7.57-7.46 (m, 2H), 6.51-6.34 (m, 3H), 6.09 (dd, J = 16.3, 10.3 Hz, 1H), 6.01-5.88 (m, 2H).
[0364] ESI-MS (m / z): [M+Na + ]Theoretical value: 813.9578, measured value: 813.9572.
[0365] Embodiment 19
[0366] Preparation method of compound No. 1157 in Table 1: (1) Synthesis of 3-(2-chlorobenzamido)-2-fluoro-N-(2-methyl-4-(perfluoropropane-2-yl)phenyl)benzamide
[0367]
[0368] 3-Amino-2-fluoro-N-(2-methyl-4-(perfluoropropane-2-yl)phenyl)benzamide (3.00 g, 7.28 mmol) was dissolved in acetonitrile, 2-chlorobenzoyl chloride (1.27 g, 7.28 mmol) was added, and the mixture was reacted at 80°C for 2 h. The crude product was spin-dried and was not further treated to obtain a light yellow solid (3.26 g, yield 81.30%).
[0369] The hydrogen nuclear magnetic resonance spectrum (400 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 10.55 (s, 1H), 10.16 (s, 1H), 8.04 (s, 1H), 7.85 (d, J = 6.7 Hz, 1H), 7.48 (dd, J = 43.5, 37.0 Hz, 8H), 2.40 (s, 3H).
[0370] (2) Synthesis of 3-(2-chloro-N-(cyclopropanecarbonyl)benzamide)-N-(cyclopropanecarbonyl)-2-fluoro-N-(2-methyl-4-(perfluoropropane-2-yl)phenyl)benzamide
[0371]
[0372] 3-(2-chlorobenzamide)-2-fluoro-N-(2-methyl-4-(perfluoropropane-2-yl)phenyl)benzamide (1.00 g, 1.82 mmol) was dissolved in ultra-dry tetrahydrofuran, sodium hydride (0.09 g, 3.64 mmol) was added in batches, stirred for 30 min under ice bath, cyclopropylcarbonyl chloride (0.57 g, 5.46 mmol) was added, and the mixture was reacted at room temperature for 2.5 h-3.5 h. After the reaction was completed, the mixture was spin-dried, dichloromethane was added, and the mixture was washed with dilute hydrochloric acid (2 mol / L), saturated sodium carbonate solution, and saturated brine in sequence, dried over anhydrous sodium sulfate, and then spin-dried under reduced pressure. Purification by silica gel column chromatography gave a light pink solid (0.55 g, 44.00%).
[0373] The hydrogen nuclear magnetic resonance spectrum (500 MHz, DMSO-d6) data of the compound are as follows (δ [ppm]): δ 7.79-7.62 (m, 5H), 7.56 (dd, J = 7.4, 1.6 Hz, 1H), 7.52-7.37 (m, 4H), 2.34 (s, 3H), 1.77-1.68 (m, 1H), 1.55-1.46 (m, 1H), 0.96-0.83 (m, 8H).
[0374] ESI-MS (m / z): [M+Na + ]Theoretical value: 709.1116, measured value: 709.1108.
[0375] Effect Example
[0376] Some of the compounds in this application form have been tested for their activity against a variety of pests.
[0377] (1) Determination of Chilo suppressalis activity:
[0378] Preparation of compound solution: Weigh 10 mg of the original drug on a balance, prepare it into 1% stock solution with DMF, and then dilute it with distilled water containing 0.1% Tween-80 to four test concentrations of 5 mg / L, 3.0 mg / L, 1.5 mg / L, and 0.75 mg / L for use.
[0379] Using the immersion method, after soaking the water chestnut slices in the medicine for 10 seconds, put them into a plastic box lined with filter paper to dry naturally in the shade. Inoculate each box with 10 3rd-instar rice stem borers and place them in an observation room at 26℃ with 16 hours of light and 8 hours of darkness. Observe the number of dead insects after 4 days.
[0380] The reference compound CK01 is represented by formula (III), the reference compound CK02 is represented by formula (IV), the reference compound CK03 is represented by formula (V), and the reference compound CK04 is represented by formula (VI):
[0381]
[0382] In Table 1, the lethality of compounds 5, 11, 25, 146, 147, 155, 156, 170, 171, 339, 345, 483, 489, 491, 492, 506, 507, 677, 681, 682, 683, 777, 791, 971, 972, 973, 978, 979, 992, 1001, 1122, 1140, and 1152 to Chilo suppressalis was greater than 80% after 4 days at a concentration of 10 mg / L. Then, the activity of compounds 147, 156, 171, 492, 507, 677, 683, 777, 791, 992, CK01, CK02, CK03, and CK04 was tested at a low concentration, and the results are shown in Table 2.
[0383] Table 2: Activity test results of some compounds in Table 1 against Chilo suppressalis
[0384]
[0385] Note: Compound numbers correspond to those in Table 1
[0386] (2) Determination of activity of Plutella xylostella:
[0387] Preparation of compound solution: Weigh 10 mg of the original drug on a balance, prepare it into 1% stock solution with DMF, and then dilute it with distilled water containing 0.1% Tween-80 to four test concentrations of 3 mg / L, 1 mg / L, 0.5 mg / L, and 0.1 mg / L for use.
[0388] Using the immersion method, the cabbage leaves were immersed in the medicine for 10 seconds and then placed in a plastic box lined with filter paper to dry naturally in the shade. Ten 3-year-old diamondback moths were inoculated into each box and placed in an observation room at 26°C with 16 hours of light and 8 hours of darkness. The number of dead insects was observed after 3 days.
[0389] Among them, compounds 5, 11, 25, 146, 147, 155, 156, 170, 171, 339, 345, 483, 489, 491, 492, 506, 507, 677, 681, 682, 683, 777, 791, 971, 972, 973, 978, 979, 992, 1001, 1122, 1140, 1152 had a mortality rate of more than 90% to Plutella xylostella at a concentration of 3 mg / L after 3 days. Then, 147, 156, 171, 492, 507, 677, 683, 777, 791, 992, CK01, CK02, CK03, and CK04 were tested for their activity at low concentrations, and the results are shown in Table 3.
[0390] Table 3: Activity test results of some compounds in Table 1 against Plutella xylostella
[0391]
[0392]
[0393] Note: Compound numbers correspond to those in Table 1
[0394] The results show that the diamide compounds provided by the present invention have high biological activity against both Chilo suppressalis and Plutella xylostella, and the diamide compounds have no cross-resistance with chlorantraniliprole. And from the comparison of the embodiments of the present application in Tables 2 and 3 with CK01, CK02, CK03, and CK04, it can be seen that the present application can enhance the lipophilicity of the diamide compounds by selecting suitable groups for R1 and R2 respectively, and the mutual coordination of suitable groups between R1 and R2, and when it is applied to the field of insecticide, it is more easily absorbed by pests, thereby having better insecticidal activity. In addition, the present application makes a special design of the diamide compound structure and the position of the grafting of R1 and R2, so that the diamide compounds have better lipophilicity, which can further enhance the efficacy of the insecticide. In pesticide organic small molecule compounds, due to the differences in substituent types, group volumes, and electronegativity, the metabolic and transport properties of the entire molecule in the body can vary greatly, and the biological activities exhibited can also vary greatly. The metabolic and transport properties of the molecule and its ability to bind to receptors are unpredictable and require a lot of creative work to learn.
[0395] The preferred embodiments are described in detail above, but the present invention is not limited to the above-mentioned specific implementation modes. Under the guidance of the present application, technicians in this field can also make various specific changes without departing from the scope of protection of the present application, which all fall within the scope of protection of the present invention.
Claims
1. A diamide compound as shown in formula (I): In formula (I), Q is any one of a substituted or unsubstituted phenyl group and a substituted or unsubstituted heterocyclic group; R1 is any one of a substituted or unsubstituted C3-C9 cycloalkyl group, a substituted or unsubstituted C2-C8 epoxyalkyl group, a substituted or unsubstituted phenyl group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted alkenyloxycarbonyl group, a substituted or unsubstituted alkynyloxycarbonyl group, a substituted or unsubstituted C1-C6 alkylthio group, a substituted or unsubstituted C2-C6 alkenyl group, a substituted or unsubstituted C2-C6 alkynyl group, a substituted C1-C6 alkyl group, a hydrogen atom, a cyano group, an amino group, a hydroxyl group, and a mercapto group; wherein, When R1 is a substituted C1-C6 alkyl, the substituent group is selected from cyano, nitro, hydroxyl, carboxyl, sulfenyl, sulfinyl, carbamoyl, aminosulfonyl, aminosulfinyl, substituted or unsubstituted phenyl, substituted or unsubstituted heterocyclic, substituted or unsubstituted amino, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, C1-C6 substituted or unsubstituted alkyl, C3-C6 substituted or unsubstituted cycloalkyl, C1-C6 substituted or unsubstituted alkoxy, C2-C6 substituted or unsubstituted alkenyl, C2-C6 substituted or unsubstituted alkynyl, substituted or unsubstituted -Si(C1-C6 alkyl)3 or one or more; Or a group represented by -L1-M-L2, wherein, L1 is selected from substituted or unsubstituted phenylene, substituted or unsubstituted heterocyclyl, substituted or unsubstituted imino, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted C1-C6 alkylene, substituted or unsubstituted C3-C9 cycloalkylene, substituted or unsubstituted C1-C6 alkyleneoxy, substituted or unsubstituted C1-C6 alkylenethio, substituted or unsubstituted C2-C8 epoxyalkylene, substituted or unsubstituted C2-C6 alkenylene, substituted or unsubstituted C2-C6 alkynylene, substituted or unsubstituted C2-C6 olefinylene, any one of oxy, substituted or unsubstituted C2-C6 alkynyleneoxy; M is selected from any one of oxygen atom, sulfur atom, carbonyl, sulfone, sulfoxide, and imino; L2 is selected from any one of hydrogen atom, substituted or unsubstituted phenyl, substituted or unsubstituted heterocyclic group, substituted or unsubstituted alkoxycarbonyl, substituted or unsubstituted alkenyloxycarbonyl, substituted or unsubstituted alkynyloxycarbonyl, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C3-C9 cycloalkyl, substituted or unsubstituted C1-C6 alkoxy, substituted or unsubstituted C2-C6 alkenyl, substituted or unsubstituted C2-C6 alkynyl; R2 is selected from any one of a hydrogen atom, a substituted or unsubstituted C1-C6 alkyl group, a substituted or unsubstituted C2-C6 alkenyl group, a substituted or unsubstituted C2-C6 alkynyl group, a substituted or unsubstituted C3-C6 cycloalkyl group, a substituted or unsubstituted C1-C6 alkylcarbonyl group, a substituted or unsubstituted C2-C6 alkenylcarbonyl group, a substituted or unsubstituted C2-C6 alkynylcarbonyl group, and a substituted or unsubstituted C3-C6 cycloalkylcarbonyl group; X1 and X2 are independently selected from any one of a hydrogen atom, a fluorine atom, a cyano group or a nitro group, and X1 and X2 are not hydrogen atoms at the same time; Y1 and Y3 are each independently any one of a hydrogen atom, a halogen atom, a cyano group, a nitro group, a C1-C6 substituted or unsubstituted alkyl group, and a C1-C6 substituted or unsubstituted alkoxy group; Y2 is a C2-C6 haloalkyl group; W is an oxygen atom or a sulfur atom.
2. The meta-diamide compound according to claim 1, characterized in that: When R1 is a substituted C2-C8 epoxyalkyl group, a substituted C3-C9 cycloalkyl group, a substituted phenyl group, a substituted heterocyclic group, a substituted alkenyloxycarbonyl group, a substituted alkynyloxycarbonyl group, a substituted C1-C6 alkylthio group, a substituted C2-C6 alkenyl group, or a substituted C2-C6 alkynyl group, the substituent group is selected from hydrogen atom, halogen atom, cyano group, nitro group, hydroxyl group, carboxyl group, mercapto group, sulfonyl group, sulfinyl group, carbamoyl group, aminosulfonyl group, aminosulfinyl group, substituted or unsubstituted phenyl group, substituted or One or more of unsubstituted heterocyclic group, substituted or unsubstituted amino group, substituted or unsubstituted alkoxycarbonyl group, substituted or unsubstituted alkenyloxycarbonyl group, substituted or unsubstituted alkynyloxycarbonyl group, C1-C6 substituted or unsubstituted alkyl group, C3-C6 substituted or unsubstituted cycloalkyl group, C1-C6 substituted or unsubstituted alkoxy group, C2-C6 substituted or unsubstituted alkenyl group, C2-C6 substituted or unsubstituted alkynyl group, substituted or unsubstituted -Si(C1-C6 alkyl)3; The substituents when L1 or L2 is a substituted group are independently selected from one or more of a hydrogen atom, a halogen atom, a cyano group, a nitro group, a hydroxyl group, a carboxyl group, a sulfhydryl group, a sulfonyl group, a sulfinyl group, a carbamoyl group, an aminosulfonyl group, an aminosulfinyl group, a substituted or unsubstituted phenyl group, a substituted or unsubstituted heterocyclic group, a substituted or unsubstituted amino group, a substituted or unsubstituted alkoxycarbonyl group, a substituted or unsubstituted alkenyloxycarbonyl group, a substituted or unsubstituted alkynyloxycarbonyl group, a C1-C6 substituted or unsubstituted alkyl group, a C3-C6 substituted or unsubstituted cycloalkyl group, a C1-C6 substituted or unsubstituted alkoxy group, a C1-C6 substituted or unsubstituted alkylthio group, a C2-C6 substituted or unsubstituted alkenyl group, a C2-C6 substituted or unsubstituted alkynyl group, and a substituted or unsubstituted -Si(C1-C6 alkyl)3; When R2 is a substituted C1-C6 alkyl, a substituted C2-C6 alkenyl, a substituted C2-C6 alkynyl, a substituted C3-C6 cycloalkyl, a substituted C1-C6 alkylcarbonyl, a substituted C2-C6 alkenylcarbonyl, a substituted C2-C6 alkynylcarbonyl, or a substituted C3-C6 cycloalkylcarbonyl, the substituent group is selected from one or more of a halogen atom, a cyano group, a C1-C6 substituted or unsubstituted alkoxy group, or a C3-C6 substituted or unsubstituted cycloalkyl group.
3. The meta-diamide compound according to claim 1 or 2, characterized in that: The R1 is a substituted or unsubstituted C2-C8 epoxyalkyl group, a substituted or unsubstituted C3-C9 cycloalkyl group, a substituted or unsubstituted C1-C3 alkyl group, a C3-C5 cycloalkyl group, a substituted or unsubstituted C3-C5 cycloalkyl group, a C1-C3 alkyl group, a cyano-substituted C1-C6 alkyl group, a substituted or unsubstituted furyl group, a substituted or unsubstituted C1-C6 alkylthio group, a substituted or unsubstituted C2-C6 alkenyl group, a substituted or unsubstituted C2-C6 Any one of an alkynyl group, a hydrogen atom, a cyano group, an amino group, a hydroxyl group, and a thiol group; wherein the substituent group in the substituted C2-C8 epoxyalkyl group, the substituted C3-C9 cycloalkyl group, the substituted C3-C5 cycloalkyl C1-C3 alkyl group, the substituted furanyl group, the substituted C1-C6 alkylthio group, the substituted C2-C6 alkenyl group, and the substituted C2-C6 alkynyl group is one or more of a C1-C3 alkyl group, a hydrogen atom, a halogen atom, a cyano group, or a furanyl group; Or a group represented by -L1-M-L2, wherein L1 is selected from any one of substituted or unsubstituted C1-C3 alkylene, substituted or unsubstituted C2-C6 alkenylene, substituted or unsubstituted C1-C3 alkyleneoxy, substituted or unsubstituted C1-C3 alkyleneamino, and substituted or unsubstituted C1-C3 alkoxycarbonyl, wherein the substituted C1-C3 alkylene, substituted C2-C6 alkenylene, substituted C1-C3 alkyleneoxy, substituted C1-C3 alkyleneamino, substituted C1-C3 alkoxycarbonyl The substituents in are one or more of hydrogen atoms, halogen atoms, cyano groups or C1-C3 alkoxy groups; M is selected from oxygen atoms, sulfur atoms or imino groups; L2 is selected from hydrogen atoms, substituted or unsubstituted C1-C3 alkyl groups, substituted or unsubstituted C2-C5 alkenyl groups, substituted or unsubstituted C1-C3 alkoxy groups, wherein the substituents of the substituted C1-C3 alkyl groups, substituted C2-C5 alkenyl groups and substituted C1-C3 alkoxy groups are one or more of hydrogen atoms, halogen atoms, cyano groups, C1-C3 alkoxy groups and C1-C3 alkylthio groups.
4. The meta-diamide compound according to claim 3, characterized in that: The R1 is any one of substituted or unsubstituted C3-C5 cycloalkyl, substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl, substituted or unsubstituted C1-C3 alkyl C3-C5 cycloalkyl C1-C3 alkyl, cyano-substituted C1-C6 alkyl, substituted or unsubstituted furyl, substituted or unsubstituted C1-C3 alkylthio, substituted or unsubstituted C2-C5 alkenyl, substituted or unsubstituted C2-C6 alkynyl, hydrogen atom, and cyano; wherein, The substituents in the substituted C3-C5 cycloalkyl, substituted C1-C3 alkyl C3-C5 cycloalkyl, substituted C1-C3 alkyl C3-C5 cycloalkyl C1-C3 alkyl, substituted C1-C3 alkoxy, substituted C1-C3 alkylthio C1-C3 alkylamino, substituted furyl, substituted C1-C3 alkoxycarbonyl, substituted C1-C3 alkyl, substituted C2-C5 alkenyl are one or more of halogen atoms, cyano, nitro or furyl; Or a group represented by -L1-M-L2, wherein L1 is selected from any one of substituted or unsubstituted C1-C3 alkylene, substituted or unsubstituted C2-C6 alkenylene, and substituted or unsubstituted C1-C3 alkyleneoxy, wherein the substituents in the substituted C1-C3 alkylene, substituted C2-C6 alkenylene, and substituted C1-C3 alkyleneoxy are one or more of halogen atoms, cyano groups, or C1-C3 alkoxy groups; M is selected from oxygen atoms; L2 is selected from hydrogen atoms, substituted or unsubstituted C1-C3 alkyl groups, and substituted or unsubstituted C2-C5 alkenyl groups, wherein the substituents in the substituted C1-C3 alkylene, substituted C2-C5 alkenyl groups are one or more of hydrogen atoms, halogen atoms, cyano groups, C1-C3 alkylthio groups, or C1-C3 alkoxy groups; The R2 is a hydrogen atom, a C1-C3 alkyl group, a C2-C5 alkenyl group, a C2-C5 alkynyl group, a C3-C5 cycloalkyl group or a C1-C3 alkyl C1-C3 alkoxy group, a C1-C3 alkylcarbonyl group, a C2-C5 alkenylcarbonyl group, a C2-C5 alkynylcarbonyl group or a C3-C5 cycloalkylcarbonyl group.
5. The meta-diamide compound according to claim 4, characterized in that: When Q is any one of substituted or unsubstituted phenyl, substituted or unsubstituted pyridyl, substituted or unsubstituted pyrimidinyl, substituted or unsubstituted thienyl, and substituted or unsubstituted pyrazinyl, the substituents in the substituted phenyl, substituted pyridyl, substituted pyrimidinyl, substituted thienyl, and substituted pyrazinyl are selected from one or more of halogen atoms, cyano, nitro, trifluoromethyl, methoxy, and trifluoromethoxy.
6. The meta-diamide compound according to any one of claims 1 to 5, characterized in that: The X1 and X2 are independently selected from hydrogen atoms or fluorine atoms, and X1 and X2 are not hydrogen atoms at the same time; the Y1 and Y3 are independently halogen atoms, C1-C3 haloalkyl, C1-C3 alkoxy or C1-C3 haloalkoxy; the Y2 is a C2-C6 fluoroalkyl; and the W is an oxygen atom.
7. The meta-diamide compound according to claim 6, characterized in that: X1 is a fluorine atom, X2 is a hydrogen atom; Y1 and Y3 are independently a bromine atom, an iodine atom, a methyl group, a methoxy group, an ethoxy group, a trifluoromethyl group, a pentafluoroethyl group, a trifluoromethoxy group, or a pentafluoroethoxy group; Y2 is a pentafluoroethyl group, a heptafluoroisopropyl group, or a nonafluoro-2-butyl group; and W is an oxygen atom.
8. A tautomer, enantiomer, diastereomer or pesticide-acceptable salt thereof of the meta-diamide compound according to any one of claims 1 to 7.
9. Use of the meta-diamide compound according to any one of claims 1 to 7 or the tautomer, enantiomer, diastereomer or pesticide-acceptable salt thereof of the meta-diamide compound according to claim 8 for preparing pesticide drugs in the fields of agriculture, forestry or health.
10. An insecticide preparation, characterized in that The insecticide comprises an active ingredient and excipients; the active ingredient comprises the diamide compound as described in any one of claims 1 to 7 and / or the tautomer, enantiomer, diastereomer or pesticide-acceptable salt thereof of the diamide compound as described in claim 8; the mass percentage of the active ingredient in the insecticide preparation is 0.1%-99%.
11. An insecticide composition, characterized in that: The insecticide composition comprises active ingredients and other active compounds; the active ingredients comprise the diamide compound as described in any one of claims 1 to 7 and / or the tautomers, enantiomers, diastereomers or pesticide-acceptable salts thereof of the diamide compound as described in claim 8; the other active compounds comprise one or more of insecticides, baits, disinfectants, miticides, nematicides, fungicides, growth regulators and herbicides; the mass percentage of the active ingredients in the insecticide composition is 1%-99%.
Citation Information
Patent Citations
Amide derivative, pest control agent containing amide derivative and pest controlling method
CN102112437A
Amide derivative, pest control agent containing the amide derivative and use of the pest control agent
CN105061248A
M-diamide compound, and preparation method and application of compound
CN108586279A
M-diamide compound as well as preparation method and application thereof
CN112142621A
Amide derivative, pest control agent containing the amide derivative and use of the pest control agent
EP2319830A1
